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The first section of this thesis describes a novel allylic isomerization, followed by an intra-
molecular Diels-Alder furan cycloaddition, fragmentation, aromatization, and N-Boc 
deprotection cascade that leads to the formation of synthetically and biologically useful 5,6,7-
substituted indoles. Various 5,6,7-substituted indoles are synthesized in moderate to good yield 
using this convergent method. Nonthermal microwave effects also prove to be essential in this 
transformation. 
The second section describes the extension of our indole synthesis methodology through 
a microwave assisted intramolecular Diels-Alder furan cycloaddition to a 5-hydroxyindole 
synthesis from readily available alkynals and alkynones. This convergent procedure is 
compatible with multiple-functionalities in the 4-position of the indole, including electron-
withdrawing and electron-donating groups. Yields range from 44 to 64%.  
The third section describes a methodology study of the alkyne isomerization reaction 
using a non-nucleophilic base. After screening of reaction conditions, optimal conditions were 
achieved by the use of 2.2 equiv of LiTMP in THF (1.0 M substrate concentration) at r.t. for 1 h.  
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1.0 TANDEM ALLYLIC ISOMERIZATION – IMDAF REACTION IN THE 
SYNTHESIS OF 5,6,7-SUBSTITUTED INDOLES 
1.1 INTRODUCTION 
1.1.1 Significance of indoles 
The indole nucleus is probably one of the most important structural components among a wide 
array of natural and unnatural compounds.
1
 Tryptophan 1, one of the essential amino acids, is a 
constituent of many proteins and the precursor of most indole alkaloids. The neurotransmitters 
serotonin 2 and melatonin 3 are involved in many biochemical pathways.
1
 The discovery of the 
plant hormone auxin 4 further increased the interest in indole chemistry (Figure 1).
1
  
 
 
 
Figure 1. Representative bioactive indoles 
1 
   
 
 
In addition, many indole alkaloids exhibit CNS activities, such as ergoline 5, yohimbine 6 
and the iboga alkaloids 7 (Figure 2).
2-5
 Indole or indoline containing-compounds are also among 
4 of the top 200 brand name drugs in 2009 (cialis 8, zeldox 9, sutent 10 and maxalt 11).
6
  
 
 
 
Figure 2. Representative natural indole alkaloids 
 
 
 
Figure 3. The top 200 brand-name drugs with indole or indoline cores in 2009 
2 
   
 
 
As a result of the importance of these heterocycles, huge efforts have been spent toward 
the synthesis and functionalization of indoles. Some well-established protocols include 
sigmatropic rearrangements (Fischer and Gassman syntheses), cyclizations (Madelung synthesis, 
Bischler synthesis) and transition metal catalyzed reactions (Larock synthesis, Fürstner synthesis 
and Castro synthesis).
7-16
  
1.1.2 The Diels-Alder reaction of furans 
The Diels-Alder cycloaddition is one of the most widely used reactions in the construction of 
complex natural products.
17
 This pericyclic reaction has proven to be broadly applicable and 
efficient in total synthesis and cascade sequences. The regio- and stereoselectivities of these 
[4+2] cycloadditions have been improved further by employing chiral auxiliaries or chiral Lewis 
acids.
18
  
The use of furans as diene components in the Diels-Alder reaction can be traced back to 
its discovery almost eighty-five years ago.
19
 The Diels-Alder reaction between dienophiles and 
furans gives rise to a substituted 7-oxabicyclo[2.2.1]hept-5-ene, which has been further 
converted into interesting synthetic products.
20
  
1.1.3 Amino-furan cycloaddition 
A variety of indolines have been prepared by Padwa and co-workers  using the intramolecular 
Diels-Alder furan cycloaddition (IMDAF) of 2-amino furans with different dienophiles.
21-24
  
3 
   
 
 
The N-Boc-2-amino furan 13, prepared by a Curtius rearrangement from furoic acid 12, 
was converted to cycloaddition precursor 15 by N-alkylation with bromide 14. The IMDAF 
reaction occurred at 165 
o
C in toluene or at 100 
o
C when 4 M ethereal LiClO4 was used in 77% 
yield. Under these conditions, the initial cycloadduct was converted into indoline 19 with a series 
of ring openings and deprotonations (Scheme 1).
25
  
 
 
Scheme 1. Intramolecular Diels-Alder reaction of 2-aminofurans 
 
The Padwa group has successfully applied this methodology to the synthesis of several 
ergoline alkaloids.
26
 The 2-amino furan intermediate 23 with pendant enone functionality was 
generated in situ from a TBS deprotection of 22. Furan 23 was transformed into the desired 
tricyclic ketone system 24 through the IMDAF reaction under thermal conditions (165 ºC in 
toluene) (Scheme 2).
26
  
4 
   
 
 
 
Scheme 2. Application of amino-furan cycloaddition in the synthesis of ergoline alkaloids 
1.1.4 IMDAF in the synthesis of 3,4-substituted indoles 
In our group’s previous work, efforts were focusing on extending the amino-furan cycloaddition 
to an indole synthesis. It was envisioned that addition of lithiated reagent 25 to various α,β-
unsaturated carbonyl compounds 26, followed by cycloaddition, dehydration aromatization and 
deprotection would give different 3,4-substituted indoles 31 (Scheme 3).
27
  
 
 
Scheme 3. Proposed indole synthesis 
5 
   
 
 
The preparation of several 4-substituted indoles was reported in good yields by subjecting 
furan-substrates to microwave irradiation (Table 1).
27
  
 
Table 1.  IMDAF in the synthesis of 4-substituted indoles 
 
6 
   
 
 
 
 
This methodology was successfully applied for the total synthesis of (±)-cycloclavine 48 
(Scheme 4).
28
 Alkylation of 49 with lithiated reagent 50 afforded the cycloaddition precursor in 
51% yield. The indole 51 was obtained by microwave irradiation in 44% isolated yield. Finally, 
reduction of indole 51 with LAH gave (±)-cycloclavine 48 in quantitative yield.  
 
 
Scheme 4. Total synthesis of (±)-cycloclavine 
7 
   
 
 
1.1.5 π-Allyl palladium complex 
1.1.5.1 Introduction 
Palladium catalyzed allylic reactions such as esterifications, aminations and alkylations have 
been an important area of research.
29
  The versatile π-allyl palladium intermediates can easily be 
formed by treatment of allyl compounds containing leaving groups with various palladium 
catalysts. This palladium complex intermediate can react with different nucleophiles, such as 
enamines and the anions derived from diethyl malonate or ethyl acetoacetate. The Tsuji-Trost 
reaction
30,31
 and Saegusa–Ito oxidation32 are two examples that utilize π-allyl palladium 
complexes. The White group has recently developed a catalytic method to generate  these 
complexes via C-H allylic activation.
33
  
1.1.5.2 Tsuji-Trost reaction 
The Pd-catalyzed allylation of carbon nucleophiles with an allylic compound via a π-allyl 
palladium complex is known as the Tsuji-Trost reaction. Tsuji first reported that a π-allyl 
palladium complex could be substituted with ethyl malonate anion (Scheme 5) in 1965.
30
 Trost 
has developed an asymmetric variant of this reaction through the use of chiral phosphine 
ligands.
31
  
 
Scheme 5. Tsuji’s allylic alkylation process 
8 
   
 
 
The accepted mechanism (Scheme 6) of the Tsuji-Trost reaction begins through 
coordination of palladium catalyst with allylic substrate 56 followed by oxidative addition and 
ligand exchange to generate the π-allyl palladium complex 58. Nucleophilic substitution 
followed by reductive elimination generates the desired product and the catalyst.
34,35
  
 
 
Scheme 6. Mechanism of Tsuji-Trost reaction 
 
Since its discovery, the Tsuji-Trost reaction has been a vibrant area of study. The 
asymmetric allylic alkylation (AAA) is tolerant of various carbon and heteroatom based 
nucleophiles and has been used as a key strategy in over 50 total syntheses.
36
  
The total synthesis of the spirocyclic alkaloid (-)-nitramine 63 is an example for an 
asymmetric allylic alkylation reaction.
37
 The allyl containing adduct 61 was afforded by the 
9 
   
 
 
reaction of allyl acetate with ketoester nucleophile 60 in the presence of palladium catalyst 52 
and phosphine ligand 62 in 81% yield (86% ee) (Scheme 7).  
 
 
Scheme 7. Asymmetric synthesis of (-)-nitramine 
 
1.1.5.3 Saegusa–Ito oxidation 
The Saegusa–Ito oxidation is another reaction that involves π-allyl palladium complexes. It was 
discovered by Saegusa in 1978 (Scheme 8).
32
 The catalytic version was developed by Larock in 
1995 by using 10 mol% of Pd(OAc)2 and an oxygen atmosphere in DMSO.
38
 The mechanism of 
this process features the formation of an oxa-π-allyl palladium complex followed by β-hydride 
elimination to give the enone products. The catalyst is regenerated through re-oxidation by 
oxygen (Scheme 9).
39,40
  
10 
   
 
 
 
Scheme 8. Saegusa–Ito oxidation 
 
 
Scheme 9. Mechanism of the Saegusa–Ito oxidation 
 
1.1.5.4 π-Allyl palladium complexes in C-H allylic oxidation 
The White group has described an electrophilic Pd(II)/sulfoxide catalyst for allylic C-H 
activation to generate the π-allyl palladium complex which can be further transformed via 
esterification,
41
 amination
42
 and alkylation.
43
 
 The mechanistic pathway begins with the sulfoxide promoted C-H cleavage followed by 
benzoquinone promoted C-H functionalization.  The catalyst is regenerated through oxidation by 
benzoquinone (Scheme 10).
33
  
11 
   
 
 
 
Scheme 10. General mechanism of allylic C-H oxidations 
 
The π-allyl palladium complex via allylic C-H activation can undergo substitution with 
various nucleophiles such as O-alkylation,
41
 N-alkylation
42
 and C-alkylation
43
 (Scheme 11).  
 
 
 
Scheme 11. Alkylation of a π-allyl palladium complex through allylic C-H oxidation 
12 
   
 
 
Active diene intermediates useful for cycloaddition can be generated from π -allyl 
palladium complexes via β-hydride elimination (Scheme 12).44  
 
 
Scheme 12. Dehydrogenative Diels-Alder reaction through allylic C-H oxidation 
1.2 RESULTS AND DISCUSSION 
1.2.1 Introduction 
We have recently reported a strategy for a convergent synthesis of 3,4-substituted indoles that 
uses an intramolecular Diels-Alder furan (IMDAF) cycloaddition.
27,28,45
 However, the limited 
stability and presumed toxicity of stannane reagent 66 prompted an alternative procedure to 
access the IMDAF intermediates. Furthermore, we were trying to avoid the high temperatures 
required for the indole cyclization reactions. Therefore, we have developed a tandem palladium 
catalyzed allylic isomerization-IMDAF process (Scheme 13) for the synthesis of indoles 
13 
   
 
 
including the 5,6- and 7- substitutions that are present in many pharmaceutical agents (Figure 
4).
1,3-5  
This procedure begins with coupling of mesylate 68 and variously substituted N-Boc-2-
aminofurans 67 to afford the allylic acetates 69.  Treatment of 69 with suitable palladium 
catalysts (vide infra) establishes an equilibrium between the thermodynamically less favored 
acetates 70 which are aligned to undergo the initial IMDAF reaction to cycloadducts 71 which 
proceed to indoles  74 via dehydrative aromatization and deprotection. 
 
 
Scheme 13. Proposed indole synthesis 
14 
   
 
 
 
Figure 4. Representative biologically active 5,6,7-substituted indoles (outlined bold) 
1.2.2 Screening of reaction conditions 
1.2.2.1 Screening of catalysts 
Various palladium catalysts, including Pd(OAc)2, Pd(CH3CN)2Cl2, and Pd(PPh3)4 have been 
used in allylic isomerization reactions.
31
 However, there are few examples of allylic 
isomerization reactions that participate in cascade processes.
46 
Initial attempts to isomerize the 
internal alkene 75 to the terminal alkene 77 using Pd(OAc)2 or Pd(CH3CN)2Cl2 failed. However, 
addition of the Pd(0) catalyst, Pd(PPh3)4, provided small amounts of the desired alkene 77 as 
determined by 
1
H NMR analysis of the crude reaction mixtures (Table 2). 
15 
   
 
 
Table 2. Catalysts screening for allylic isomerization
a
 
 
Entry Catalyst
b
  mol%  Temperature Results
c
 
1 Pd(OAc)2  3  70 
o
C  75 (66%) + 76 (34%) 
2 Pd(CH3CN)2Cl2 20  100 
o
C  75 (80%) + 76 (20%) 
3 Pd(PPh3)4  5  70 
o
C  75 (63%) + 76 (27%) + 77 (10%) 
a
Reactions were usually carried out in a 1.0 M concentration (80 mg in 0.3 mL of THF) for 4 h.  bPercentage refers to the 
ratio determined by crude 
1
H NMR analysis. 
 
1.2.2.2 Screening of temperature 
With these encouraging preliminary results, we decided to investigate the reaction temperatures 
necessary to promote the IMDAF process. In our previous report
27
, microwave irradiation at 
temperatures exceeding 180 
o
C was required for the IMDAF reaction in the synthesis of 4-
substituted indoles. Efforts to lower the reaction temperatures in the palladium catalyzed process 
failed to give cycloaddition products. A modest yield of indole 78 was obtained when allylic 
acetate was subjected to 180 
o
C for 20 min under microwave conditions (Entry 5, Table 3). 
 
 
 
16 
   
 
 
Table 3. Temperature screening
a 
 
 
 
Entry Temperature
 
Time  Results
c 
1
b
 70 
o
C  4 h  75 (50%) + 76 (22%) + 77 (8%) 
2
b
 100 
o
C  18 h  75 (6%) + 76 (27%) + 77 (9%) + 79 (33%) 
3 130 
o
C  1 h  76 (22%) + 79 (43%) + 80 (21%) 
4 150 
o
C  1 h  79 (59%) + 80 (29%) 
5 180 
o
C  20 min  78 (19%)  
a
All reactions were carried out with 5 mol% Pd(PPh3)4 and 20 mol% PPh3 under microwave irradiation in a 
concentration of 1.0 M (80 mg in 0.3 mL NMP). 
b
Conventional heating. 
c
Isolated yields. 
1.2.2.3 Screening of ligands 
Due to the instability of indole under these elevated temperatures, we changed the allylic acetate 
substrate to 81a which would provide the more stable 3-methyl indole 82.  
 
17 
   
 
 
The evaluation of various ligands revealed that strong electron donating ligands like 
P(OR)3 (Entry 5, 9, Table 4) significantly improved the formation of the desired 3-methyl 
indole 82. It was also demonstrated that microwave heating was preferred as conventional 
heating was unsuccessful which suggests that nonthermal microwave effects
47-49
 are essential for 
this transformation. 
Table 4. Ligand screening for cyclization
a 
 
Entry  Ligand  Yield
b 
 Entry  Ligand  Yield
b 
1  dppb  59%  7  PPh3  45% 
2  dppe  48%  8   P(tBu)3 0 
3  dppp   40%  9  P(OEt)3 71% 
4  PBn3  74%  10  PH(tBu)2O 21% 
5  P(OiPr)3 83%  11  P(OPh)3 27% 
6  P(nBu)3 25%  12
c
  P(OiPr)3 0 
a
All reactions were carried out with 5 mol% Pd(PPh3)4 and 20 mol% ligand under microwave irradiation in a 
concentration of 0.1 M in NMP at 180 
o
C for 20 min. 
b
Isolated yields. 
 
18 
   
 
 
1.2.2.4 Variation of concentration 
The optimal reaction concentrations were at 0.1-0.2 M which provided indole 82 in 74 and 72% 
yield, respectively. More dilute conditions gave <10% conversion of starting material (Table 5). 
 
Table 5. Concentration variation for cyclization
a 
 
Entry Concentration  Yield
b
   Entry  Concentration  Yield
b 
1 1.0 M   49%  4  0.2 M   72% 
2 0.5 M   48%  5   0.1 M   74% 
3 0.3 M    52%  6  0.04 M   <10% 
a
All reactions were carried out with 5 mol% Pd(PPh3)4 and 20 mol% PBn3 under microwave irradiation in NMP at 
180 
o
C for 20 min. 
b
Isolated yields. 
 
1.2.2.5 Variation of catalyst loading 
These initial investigations used 5 mol% catalyst loadings, and efforts to decrease the catalyst (1-
2 mol%) were unproductive and resulted only in recovery of starting materials.  Slightly lower 
yields of the indole products were obtained by increasing the catalyst loading (10 and 20 mol%) 
which could be attributed to palladium-mediated indole oxidations (Table 6).  
19 
   
 
 
Table 6. Catalyst loading variation for cyclization
a
 
 
Entry  Catalyst Loading  Ligand Loading  Yields
b
 
 
1  0    0    0 
2  1 mol%   4 mol%   0 
3  2 mol%   8 mol%   0 
4  5 mol%   20 mol%   83% 
5  10 mol%   40 mol%   75% 
6  20 mol%   80 mol%   71% 
a
All reactions were carried out with Pd(PPh3)4 as catalyst and P(OiPr)3 as ligand under microwave irradiation in a 
concentration of 0.2 M in NMP at 180 
o
C for 20 min. 
b
Isolated yields. 
 
1.2.2.6 Screening of leaving groups 
The Tsuji-Trost reaction displays marked differences in the substrate reactivities containing 
various leaving groups.
29
 However, the palladium mediated conversion of 81 to indole 82 using 
the acetyl and benzoate esters as well as methyl carbonates provided comparable results (Table 
7). 
 
 
20 
   
 
 
 
Table 7. Leaving group screening for cyclization
a 
 
Entry   R
  
Ligand  Yield
b 
1  81a, Ac PPh3  40%  
2  81b, Bz PPh3  49%  
3  81c, COOMe PPh3  37%   
4  81a, Ac PBn3  50% 
5   81b, Bz PBn3  48% 
6  81c, COOMe  PBn3  46% 
a
All reactions were usually carried out with 5 mol% Pd(PPh3)4 and 20 mol% PPh3 under microwave irradiation in a 
concentration of 1.0 M (80 mg in 0.3 mL NMP) at 180 
o
C for 20 min. 
b
Isolated yields. 
 
1.2.2.7 Screening of protecting groups 
Padwa has reported that an ethyl carbamate group gives a higher yield for indoline formation 
compared to the N-Boc group due to enhanced thermal stability (Scheme 14, above).
25
 However, 
the use of the ethyl carbamate derivative under our reaction conditions gave the carbamate-
substituted indole 23 in lower yield (Scheme 14, below). 
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  83a, R
 
= Boc   84a, R = Boc, 25%  
  83b, R = COOEt  84b, R
 
= COOEt, 82% 
 
 
  81a, R
1 
= Boc    82, R
2
 = H, 83% 
  85, R
1
 =  COOEt   86, R
2 
= COOEt, 65% 
Scheme 14. Protecting group screening for cyclization 
 
1.2.3 Proposed mechanism 
A proposed mechanism is outlined in Scheme 15 with presumed coordination of palladium 
catalyst with allylic acetate 69 followed by oxidative addition to give intermediate 88. After 
ligand exchange, the π-allyl palladium complex 89 is formed which undergoes an intra-
molecular Diels-Alder reaction to form the tricyclic adduct 90. Reductive elimination with 
catalyst dissociation affords 91 which proceeds to indole 94 via iminium isomerization and 
dehydration.  
22 
   
 
 
 
Scheme 15. Proposed mechanism 
1.2.4 Examples of the IMDAF reaction for the synthesis of 5,6,7-substituted indoles 
With optimal reaction conditions determined (5 mol% Pd(PPh3)4, 20 mol% P(OiPr)3, microwave 
irradiation at 180 
o
C for 20 min in 0.2 M substrate concentration), the scope and generality of the 
reaction was evaluated. This process was compatible with 5-furyl substitutions to give the 3-
methyl-5-substituted indoles with the best yields arising from electron-donating functionalities 
(Entries 7-9, Table 8). In general, indoles with 3-, 3,5-, and 3,7- substitutions were obtained in 
moderate to good yields. An attempt to prepare trisubstituted indoles (3,5,6-substitutions, Entry 
12, Table 8) gave a significantly lower yield. 
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Table 8. Scope of the tandem allylic isomerization – IMDAF reaction in the synthesis of indoles 
Entry  Precursor   Product     Yield 
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Entry  Precursor   Product      Yield 
 
 
1.2.5 Synthesis of precursors 
The precursors for the tandem allylic isomerization – IMDAF reaction were derived from the N-
alkylation of the substituted N-Boc-protected 2-aminofuran 67 with bromide 118. The Curtius 
rearrangement of furoic acid 117 was expected to produce 67 (Scheme 16). 
 
 
Scheme 16. Retrosynthetic analysis of the precursors for the tandem tandem palladium-catalyzed allylic 
isomerization – IMDAF reaction 
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A general example of this sequence is represented by the conversion of acid 120 into 2-
aminofuran 121 by treatment with DPPA in t-BuOH. Alkylation of 121 with bromide 118 gave 
precursor 107 in good yield (67%) (Scheme 17). Additional substrates were also prepared using 
this reaction sequence (Table 9). 
 
 
Scheme 17. Representative synthesis of the precursor for the tandem tandem palladium-catalyzed allylic 
isomerization – IMDAF reaction 
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Table 9. Preparation of N-Boc-protected 2-aminofurans 
Entry   2-Aminofuran          Yield          Indole Precursors        Yield
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Entry   2-Aminofuran   Yield  Indole Precursors  Yield
 
 
1.2.6 Conclusions 
In summary, we have extended our indole synthesis methodology to 5,6,7-substituted indoles via 
the IMDAF reaction. This new protocol avoids the use of tin-containing intermediates and 
features a microwave assisted allylic-isomerization IMDAF reaction. This convergent procedure 
is tolerant of multiple-functionalities and generates indole products with substitution patterns that 
are difficult to access using previously established methods. 
1.3 EXPERIMENTAL SECTION 
General Information: All reactions were performed under an N2 or argon atmosphere and all 
glassware was dried in an oven at 140 °C for 2 h prior to use. Reactions carried out at -78 °C 
28 
   
 
 
employed a CO2/acetone bath. THF was distilled over sodium/benzophenone ketyl, and CH2Cl2 
was purified using an alumina column filtration system. DMF were dried from 4 Å molecule 
sieves. Pyridine and Et3N were dried from KOH. Reactions were monitored by TLC analysis 
(EM Science pre-coated silica gel 60 F254 plates, 250 mM layer thickness) a PMA solution (5 g 
of phosphomolybdic acid in 100 mL of 95% EtOH), p-anisaldehyde solution (2.5 mL of p-
anisaldehyde, 2 mL of AcOH, and 3.5 mL of conc. H2SO4 in 100 mL of 95% EtOH), Vaughn’s 
reagent (4.8 g of (NH4)6Mo7O24•4 H2O and 0.2 g of Ce(SO4)2 in 100 mL of a 3.5 N H2SO4 
solution) or a KMnO4 solution (1.5 g of KMnO4 and 1.5 g of K2CO3 in 100 mL of a 0.1% NaOH 
solution).  Purifications by chromatography were performed using SiO2 (SiliaFlash
®
 F60, 
Silicycle) or using an ISCO- Companion flash chromatography system. 
1
H/
13
C NMR spectra 
were recorded on Bruker Avance 300/75 MHz, Bruker Avance 400/100 MHz or  Bruker Avance 
500/125 MHz instrument. Chemical shifts were reported in parts per million with the residual 
solvent peak used as the internal standard. Chemical shifts were tabulated as follows: chemical 
shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quarter, dd = doublet of doublet, dt = 
doublet of triplet, m = multiplet, br = broad, app = apparent), coupling constants, and integration. 
Mass spectra were obtained on a Micromass Autospec double focusing instrument. IR spectra 
were obtained on an Identity IR-ATR spectrometer. Microwave reactions were performed using 
a Biotage Initiator in glass microwave vials (cap sealed) with continuous magnetic stirring and 
an external surface temperature sensor. LCMS analyses were completed on a Waters MicroMass 
ZQ with 2525 Binary Gradient Module, 2420 ELSD, 2996 PDA using MeCN/H2O with 0.1% 
TFA. Melting points (uncorrected) were determined using a Mel-Temp instrument. 
29 
   
 
 
 
(Z)-4-((tert-Butoxycarbonyl)(furan-2-yl)amino)but-2-en-1-yl acetate (75). To a 
solution of 2-N-Boc-furyl amine
27
 (971.3 mg, 5.302 mmol) in dry DMF (7.0 mL) at 0 
o
C was 
added NaH (318.1 mg, 7.953 mmol, 60 % in mineral oil) in 4 portions. The reaction mixture was 
stirred at 0 
o
C for 2 h. Then, (Z)-4-((methylsulfonyl)oxy)but-2-en-1-yl acetate
50
 (498.6 mg, 
3.355 mmol) was added dropwise over 5 min. The resulting solution was stirred at 0 
o
C for 2 h 
and r.t. for 2 h, diluted with Et2O (5 mL), quenched with saturated aqueous NH4Cl (5 mL), 
extracted with Et2O (3 x 15 mL), washed with water and brine, dried and concentrated under 
reduced pressure. The crude product was purified by chromatography on SiO2 (hexanes : EA = 
15 : 1) to give 75 (939.2 mg, 60%) as a pale yellow liquid: ATR-IR (neat) 2954, 2922, 2852, 
1713, 1685, 1368, 1236, 1206, 1150, 1025 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 7.17 (dd, 1 H, J 
= 0.8, 2.0 Hz), 6.32 (dd, 1 H, J = 2.4, 3.2 Hz), 6.00 (br, 1 H), 5.74 (ttd, 1 H, J = 1.2, 6.8, 10.8 
Hz), 5.66 (ttd, 1 H, J = 1.2, 6.8, 11.2 Hz), 4.59 (d, 2 H, J = 6.4 Hz), 4.27 (d, 2 H, J = 6.8 Hz), 
2.04 (s, 3 H), 1.45 (s, 9 H); 
13
C NMR (CDCl3, 100 MHz) δ 170.2, 153.1, 147.8, 137.8, 129.4, 
126.2, 110.6, 100.8, 81.0, 59.5, 45.0, 27.8, 20.4; MS (ESI) m/z (%) 318 ([M+Na]
+
, 27), 259 (56), 
218 (100), 203 (50), 136 (29); HRMS (EI) m/z calcd for C15H21NO5Na ([M+Na]
+
) 318.1317, 
found 318.1328.    
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(E)-4-((tert-Butoxycarbonyl)(furan-2-yl)amino)-3-methylbut-2-en-1-yl acetate (81a). 
To a solution of 2-N-Boc-furyl amine
27
 (413.1 mg, 2.255 mmol) in dry DMF (5.0 mL) at 0 
o
C 
was added NaH (135.2 mg, 3.382 mmol, 60 % in mineral oil) in 4 portions. The reaction mixture 
was stirred at 0 
o
C for 1 h. Then, (E)-4-bromo-3-methylbut-2-en-1-yl acetate
51
 (490.3 mg, 
2.368 mmol) was added dropwise over 5 min. The resulting solution was stirred at 0 
o
C for 4 h, 
diluted with Et2O (5 mL), quenched with saturated aqueous NH4Cl (5 mL), extracted with Et2O 
(3 x 15 mL), washed with water and brine, dried (Na2SO4), filtered and concentrated under 
reduced pressure. The crude product was purified by chromatography on SiO2 (hexanes : EA = 
15 : 1) to give the product 81a (539.3 mg, 77%) as a pale yellow liquid: ATR-IR (neat) 2973, 
2932, 1735, 1709, 1610, 1506, 1504, 1364, 1228, 1158, 1051, 1021, 1003, 857, 766, 736 cm
-1
;
 
1
H NMR (CDCl3, 500 MHz) δ 7.15 (dd, 1 H, J = 1.0, 2.0 Hz), 6.31 (dd, 1 H, J = 2.0, 3.0 Hz), 
5.98 (br, 1 H), 5.43 (qt, 1 H, J = 1.0, 7.0 Hz), 4.58 (d, 2 H, J =  7.0 Hz), 4.11 (s, 2 H), 2.02 (s, 3 
H), 1.71 (s, 3 H, J = 1.2 Hz), 1.44 (s, 9 H); 
13
C NMR (CDCl3, 125 MHz) δ 170.9, 153.9, 148.3, 
138.1, 137.2, 120.2, 110.8, 101.1, 81.3, 60.8, 55.3, 28.1, 20.9, 14.3. MS (ESI) m/z (%) 332 
([M+23]
+
, 100), 276 (42), 232 (90); HRMS (ESI) m/z calcd for C16H23NO5Na ([M+Na]
+
) 
332.1474, found 332.1465. 
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3-Methyl-1H-indole (82). To a solution of 81a (55.5 mg, 0.179 mmol) and P(OiPr)3 
(8.90 μL, 0.0359 mmol) in NMP (1.8 mL) was added Pd(PPh3)4 (10.4 mg, 0.00897 mmol). The 
reaction mixture was stirred under microwave irradiation at 180 
o
C for 20 min, quenched with 
ether and water, extracted with ether, washed with brine, dried (Na2SO4), filtered and 
concentrated under reduced pressure. The residue was purified by chromatography on SiO2 
(hexanes : EA = 16 : 1) to give 82 (19.5 mg, 83%) as a yellow solid: Mp 89.2–90.6 oC; ATR-IR 
(neat) 3413, 2921, 736 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 7.87 (br, 1 H), 7.60 (d, 1 H, J = 7.6 
Hz), 7.36 (d, 1 H, J = 8.0 Hz), 7.20 (dt, 1 H, J = 0.8, 8.0 Hz), 7.14 (dt, 1 H, J = 1.2, 8.0 Hz), 6.98 
(d, 1 H, J = 1.2 Hz), 2.35 (d, 3 H, 0.8 Hz); 
13
C NMR (CDCl3, 100 MHz) δ 136.2, 128.3, 121.8, 
121.5, 119.1, 118.8, 111.7, 110.9, 9.6; MS (EI) m/z (%) 131 ([M]
+
, 57), 130 (100), 86 (55), 84 
(82); HRMS (EI) m/z calcd for C9H9N 131.0735, found 131.0703. The spectral data were 
consistent with those reported in the literature.
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(E)-tert-Butyl furan-2-yl(4-hydroxy-2-methylbut-2-en-1-yl)carbamate (133). To a 
solution of 81a (222.0 mg, 0.7176 mmol) in methanol (2.5 mL) was added dropwise an aqueous 
solution of 20% K2CO3 (0.6 mL). The reaction mixture was stirred at r.t. for 2 h, quenched with 
dilute HCl, concentrated under reduced pressure. The residue was purified by chromatography 
on SiO2 (hexanes : EA = 2 : 1) to give 133 (185.2 mg, 97%) as a pale yellow liquid: ATR-IR 
32 
   
 
 
(neat) 3502, 3008, 2982, 2969, 2932, 2880, 1700, 1610, 1389, 1364, 1288, 1252, 1234, 1212, 
1158, 1146,  1055, 1010, 999, 852, 762, 736, 699 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 7.09 (dd, 
1 H, J = 0.8, 2.0 Hz), 6.24 (dd, 1 H, J = 2.4, 3.2 Hz), 5.93 (br, 1 H), 5.41 (qt, 1 H, J = 0.8, 6.4 
Hz), 4.05 (d, 2 H, J =  7.2 Hz), 4.05 (s, 2 H), 2.39 (br, 1 H), 1.61 (s, 3 H), 1.39 (s, 9 H); 
13
C 
NMR (CDCl3, 100 MHz) δ 153.9, 148.1, 137.9, 133.8, 125.5, 110.6, 101.0, 81.1, 58.6, 55.3, 
27.9, 14.0; MS (EI) m/z (%) 267 ([M]
+
, 16), 167 (59), 149 (83), 83 (100), 68 (98); HRMS (EI) 
m/z calcd for C14H21NO4Na ([M+Na]
+
) 290.1368, found 290.1358. 
 
 
(E)-4-((tert-Butoxycarbonyl)(furan-2-yl)amino)-3-methylbut-2-en-1-yl benzoate 
(81b). To a solution of 2-N-Boc-furyl amine
27
 (265 mg, 1.45 mmol) in dry DMF (2.5 mL) at 0 
o
C was added NaH (86.8 mg, 2.17 mmol, 60 % in mineral oil) in 4 portions. The reaction 
mixture was stirred at 0 
o
C for 1 h. Then, (E)-4-bromo-3-methylbut-2-en-1-yl benzoate
53
 (409 
mg, 1.52 mmol) was added dropwise over 5 min. The resulting solution was stirred at 0 
o
C for 2 
h, diluted with Et2O (5 mL), quenched with saturated aqueous NH4Cl (5 mL), extracted with 
Et2O (3 x 15 mL), washed with water and brine, dried, filtered and concentrated under reduced 
pressure. The crude product was purified by chromatography on SiO2 (hexanes : EA = 15 : 1) to 
give 81b (329 mg, 61%) as a colorless liquid: ATR-IR (neat) 2980, 2971, 2930, 2880, 1705, 
1610, 1504, 1450, 1390, 1366, 1269, 1158, 1146, 1072, 1057, 1012, 945, 913, 854, 744, 712 cm
-
1
;
 1
H NMR (CDCl3, 400 MHz) δ 8.02 (td, 2 H, J = 1.6, 7.6 Hz), 7.55 (tt, 1 H, J = 1.2, 7.2 Hz), 
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7.43 (t, 2 H, J = 1.6, 8.0 Hz), 7.14 (dd, 1 H, J = 0.8, 2.0 Hz), 6.28 (dd, 1 H, J = 2.4, 2.8 Hz), 5.99 
(br, 1 H), 5.57 (qt, 1 H, J = 1.2, 6.8 Hz), 4.84 (d, 2 H, J =  7.2 Hz), 4.15 (s, 2 H), 1.79 (s, 3 H), 
1.44 (s, 9 H); 
13
C NMR (CDCl3, 100 MHz) δ 166.4, 153.9, 148.3, 138.1, 137.5, 132.8, 130.3, 
129.6, 128.3, 120.4, 110.8, 101.2, 81.4, 61.3, 55.4, 28.1, 14.5; MS (EI) m/z (%) 371 ([M]
+
, 56), 
271 (60), 149 (82), 105 (100), 77 (79), 68 (93); HRMS (ESI) m/z calcd for C21H25NO5Na 
([M+Na]
+
) 394.1630, found 394.1643. 
 
 
(E)-tert-Butylfuran-2-yl(4-((methoxycarbonyl)oxy)-2-methylbut-2-en-1-
yl)carbamate (81c). To a solution of 133 (276 mg, 1.03 mmol) in dry CH2Cl2 (2 mL) and 
pyridine (0.420 mL, 5.20 mmol) was added methyl chloroformate (0.120 mL, 1.50 mmol) at 0 
o
C. The reaction mixture was stirred at 0 
o
C for 15 min, quenched with CH2Cl2 (5 mL) and 1 N 
HCl solution (5 mL), washed with brine, dried (Na2SO4), filtered and concentrated under reduced 
pressure. The residue was purified by chromatography on SiO2 (hexanes : EA = 8 : 1) to give 81c 
(193 mg, 58%) as a pale yellow liquid: ATR-IR (neat) 3004, 2977, 2975, 2861, 1746, 1709, 
1444, 1441, 1366, 1333, 1256, 1156, 1057, 1008, 941, 859, 790 cm
-1
; 
1
H NMR (CDCl3, 400 
MHz) δ 7.15 (dd, 1 H, J = 0.8, 2.0 Hz), 6.30 (dd, 1 H, J = 2.0, 2.8 Hz), 5.98 (br, 1 H), 5.46 (qt, 1 
H, J = 1.6, 7.2 Hz), 4.66 (d, 2 H, J =  7.2 Hz), 4.12 (s, 3 H), 3.76 (s, 3 H), 1.73 (s, 3 H), 1.44 (s, 9 
H); 
13
C NMR (CDCl3, 100 MHz) δ 155.6, 153.7, 148.1, 138.0, 138.0, 119.5, 110.7, 101.0, 81.2, 
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64.0, 55.1, 54.6, 28.0, 14.3. HRMS (ESI) m/z calcd for C16H23NO6Na ([M+Na]
+
) 348.1423, 
found 348.1448. 
 
 
(E)-4-((Ethoxycarbonyl)(furan-2-yl)amino)-3-methylbut-2-en-1-yl acetate (85). To a 
solution of ethyl furan-2-ylcarbamate (445 mg, 2.87 mmol) in dry DMF (5 mL) at 0 
o
C was 
added NaH (172 mg, 4.30 mmol, 60 % in mineral oil) in 1 portion. The reaction mixture was 
stirred at 0 
o
C for 1 h. Then, (E)-4-bromo-3-methylbut-2-en-1-yl acetate
51
 (623 mg, 3.01 
mmol) was added dropwise over 5 min. The resulting solution was stirred at r.t. for 2 h, diluted 
with Et2O (5 mL), quenched with saturated aqueous NH4Cl (5 mL), extracted with Et2O (3 x 10 
mL), washed with water and brine, dried and concentrated under reduced pressure. The crude 
product was purified by chromatography on SiO2 (hexanes : EA = 15 : 1) to give 85 (435 mg, 54 
%) as a pale yellow liquid:
 
ATR-IR (neat) 2978, 2932, 2915, 2848, 1713, 1612, 1504, 1444, 
1402, 1370, 1348, 1271, 1230, 1156, 1144, 1055, 1021, 738, 770, 714 cm
-1
; 
1
H NMR (CDCl3, 
500 MHz) δ 7.17 (dd, 1 H, J = 1.0, 2.0 Hz), 6.32 (dd, 1 H, J = 2.0, 3.0 Hz), 6.01 (br, 1 H), 5.43 
(qt, 1 H, J = 1.0, 6.5 Hz), 4.57 (d, 2 H, J = 6.5 Hz), 4.20-4.16 (m, 4 H), 2.02 (s, 3 H), 1.71 (s, 3 
H), 1.23 (t, 3 H, J = 6.5 Hz); 
13
C NMR (CDCl3, 100 MHz) δ 170.8, 155.1, 147.5, 138.5, 136.7, 
120.8, 110.8, 101.9, 62.3, 60.7, 55.6, 20.9, 14.4, 14.3; HRMS (ESI) m/z calcd for C14H19NO5 
([M]
+
) 281.1251, found 281.1263. 
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Ethyl 3-methyl-1H-indole-1-carboxylate (86). To a solution of 85 (74.0 mg, 0.263 
mmol) and P(OiPr)3 (11.0 mg, 0.0526 mmol) in NMP (1.40 mL) was added Pd(PPh3)4 (15.2 mg, 
0.0131 mmol). The reaction mixture was stirred under microwave radiation at 180 
o
C for 20 min, 
quenched with ether and water, extracted with ether, washed with brine, dried (Na2SO4), filtered 
and concentrated under reduced pressure. The residue was purified by chromatography on SiO2 
(hexanes : EA = 50 : 1) to give 86 (34.8 mg, 65%) as a colorless liquid:
 1
H NMR (CDCl3, 500 
MHz) δ 8.15 (br, 1 H), 7.50 (ddd, 1 H, J = 1.0, 1.0, 7.5 Hz), 7.38 (br, 1 H), 7.33 (dt, 1 H, J = 1.0, 
8.0 Hz), 7.26 (dt, 1 H, J = 1.0, 8.0 Hz), 4.46 (q, 2 H, J = 7.0 Hz), 2.26 (d, 3 H, J = 1.0 Hz), 1.45 
(t, 3 H, J = 7.0 Hz). The spectral data were consistent with those reported in the literature.
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tert-Butyl (5-methylfuran-2-yl)carbamate (134). To a stirred solution of 5-methyl-2-
furoic acid (667 mg, 5.29 mmol) in t-BuOH (2.0 mL) was added DPPA (1.14 mL, 5.29 mmol) 
and TEA (1.49 mL, 10.6 mmol). The reaction mixture was refluxed behind the protective shield 
and under constant flow of argon for 11 h. The reaction was quenched by NaOH solution (1.0 M), 
extracted with ethyl acetate, washed with brine, dried (Na2SO4) and concentrated to give a 
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residue that was purified by chromatography on SiO2 (Hexane : EA = 15 : 1) to give 134 (903 
mg, 87%) as a white solid: 
1
H NMR (CDCl3, 400 MHz) δ 6.45 (s, 1 H), 5.90 (brs, 2 H), 2.21 (s, 3 
H), 1.49 (s, 9 H). The spectral data were consistent with those reported in the literature.
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(E)-4-((tert-Butoxycarbonyl)(5-methylfuran-2-yl)amino)-3-methylbut-2-en-1-yl 
acetate (95). To a solution of 134 (126 mg, 0.640 mmol) in dry DMF (2.0 mL) at 0 
o
C was 
added NaH (38.4 mg, 0.960 mmol, 60 % in mineral oil) in 4 portions. The reaction mixture was 
stirred at 0 
o
C for 1 h. Then, (E)-4-bromo-3-methylbut-2-en-1-yl acetate
51
 (139 mg, 0.672 
mmol) was added dropwise over 5 min. The resulting solution was stirred at r.t. for 2 h, diluted 
with Et2O (10 mL), quenched with saturated aqueous NH4Cl (10 mL), extracted with Et2O (3 x 
10 mL), washed with water and brine, dried and concentrated under reduced pressure. The crude 
product was purified by chromatography on SiO2 (hexanes : EA = 15 : 1) to give 95 (105 mg, 
51%) as a pale yellow liquid: ATR-IR (neat) 2977, 2928, 1737, 1709, 1616, 1571, 1364, 1228, 
1159, 1057, 1020, 956, 859, 775, 738 cm
-1
;
 1
H NMR (CDCl3, 500 MHz) δ 5.88 (s, 1 H), 5.84 (br, 
1 H), 5.44 (t, 1 H, J = 7.0 Hz), 4.59 (d, 2 H, J = 6.5 Hz), 4.08 (s, 2 H), 2.22 (s, 3 H), 2.03 (s, 3 
H), 1.71 (s, 3 H), 1.44 (s, 9 H); 
13
C NMR (CDCl3, 125 MHz) δ 171.0, 154.2, 147.8, 146.3, 137.4, 
120.2, 106.4, 102.4, 81.1, 60.9, 60.4, 28.1, 21.0, 14.4, 13.6; HRMS (ESI) m/z calcd for 
C17H25NO5Na ([M+Na]
+
) 346.1630, found 346.1613. 
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3,5-Dimethyl-1H-indole (96). To a solution of 95 (33 mg, 0.10 mmol) and P(OiPr)3 (4.3 
mg, 0.021 mmol) in NMP (0.51 mL) was added Pd(PPh3)4 (5.9 mg, 0.0051 mmol). The reaction 
mixture was stirred under microwave radiation at 180 
o
C for 20 min, quenched with ether and 
water, extracted with ether, washed with brine, dried (Na2SO4), filtered and concentrated under 
reduced pressure. The residue was purified by chromatography on SiO2 (hexanes : EA = 16 : 1) 
to give 96 (13 mg, 84%) as a yellow solid: Mp 70.9–72.6 oC; ATR-IR (neat) 3409, 2919, 742 
cm
-1
; 
1
H NMR (CDCl3, 500 MHz) δ 7.78 (br, 1 H), 7.37 (d, 1 H, J = 1.0 Hz), 7.24 (d, 1 H, J = 
8.5 Hz), 7.02 (dd, 1 H, J = 1.0, 8.5 Hz), 6.94 (d, 1 H, J = 1.0 Hz), 2.47 (s, 3 H), 2.31 (d, 3 H, J = 
1.0 Hz); 
13C NMR (CDCl3, 125 MHz) δ 134.5, 128.5, 128.3, 123.4, 121.7, 118.5, 111.2, 110.6, 
21.5, 9.6; HRMS (EI) m/z calcd for C10H10N ([M-H]
+
) 144.0813, found 144.0798. The spectral 
data were consistent with those reported in the literature.
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tert-Butyl (3-methylfuran-2-yl)carbamate (135). To a stirred solution of  3-methyl-2-
furoic acid (309 mg, 2.45 mmol) in t-BuOH (5 mL) was added DPPA (0.529 mL, 2.45 mmol) 
and Et3N (0.689 mL, 4.91 mmol). The reaction mixture was refluxed behind the protective shield 
and under constant flow of argon for 12 h. The reaction was quenched by NaOH solution (1.0 
M), extracted with ethyl acetate, washed with brine, dried (Na2SO4), filtered and concentrated to 
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give a residue that was purified by chromatography on SiO2 (hexanes : EA = 15 : 1) to give 135 
(361 mg, 75%) as a white solid: 
1
H NMR (CDCl3, 400 MHz) δ 7.13 (d, 1 H, J =2.0 Hz), 6.21 (d, 
1 H, J = 2.0 Hz), 6.05 (br, 1 H), 1.93 (s, 3 H), 1.47 (s, 9 H). The spectral data were consistent 
with those reported in the literature.
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(E)-4-((tert-Butoxycarbonyl)(3-methylfuran-2-yl)amino)-3-methylbut-2-en-1-yl 
acetate (97). To a solution of 135 (361 mg, 1.83 mmol) in dry DMF (5.0 mL) at 0 
o
C was added 
NaH (110 mg, 2.74 mmol, 60 % in mineral oil) in 4 portions. The reaction mixture was stirred at 
0 
o
C for 1 h. Then, (E)-4-bromo-3-methylbut-2-en-1-yl acetate
51
 (398 mg, 1.92 mmol) was 
added dropwise over 5 min. The resulting solution was stirred at r.t. for 2 h, diluted with Et2O 
(10 mL), quenched with saturated aqueous NH4Cl (10 mL), extracted with Et2O (3 x 10 mL), 
washed with water and brine, dried (Na2SO4), filtered and concentrated under reduced pressure. 
The crude product was purified by chromatography on SiO2 (hexanes : EA = 15 : 1) to give 97 
(320 mg, 54%) as a colorless liquid: ATR-IR (neat) 2977, 2928, 1737, 1709, 1646, 1508, 1364, 
1228, 1159, 1094, 1053, 1021, 887, 861, 740 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) δ 7.09 (s, 1 H), 
6.16 (s, 1 H), 5.42 (t, 1 H, J = 6.5 Hz), 4.55 (d, 2 H, J = 6.5 Hz), 4.05 (s, 2 H), 2.01 (s, 3 H), 1.85 
(s, 3 H), 1.72 (s, 3 H), 1.39 (s, 9 H); 
13
C NMR (CDCl3, 125 MHz) δ 170.8, 154.5, 144.0, 138.2, 
137.6, 137.2, 121.1, 112.9, 80.8, 60.8, 55.2, 28.1, 20.9, 14.5, 9.5; HRMS (ESI) m/z calcd for 
C17H25NO5Na ([M+Na]
+
) 346.1630, found 346.1616. 
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3,7-Dimethyl-1H-indole (98). To a solution of 97 (46 mg, 0.14 mmol) and P(OiPr)3 (5.9 
mg, 0.028 mmol) in NMP (0.70 mL) was added Pd(PPh3)4 (8.1 mg, 0.0081 mmol). The reaction 
mixture was stirred under microwave irradiation at 180 
o
C for 20 min, quenched with ether and 
water, extracted with ether, washed with brine, dried (Na2SO4), filtered and concentrated under 
reduced pressure. The residue was purified by chromatography on SiO2 (hexanes : EA = 16 : 1) 
to give 98 (18 mg, 86%) as a yellow solid: Mp 57.3–59.1 oC; ATR-IR (neat) 3417, 2921, 742 
cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 7.81 (br, 1 H), 7.46 (d, 1 H, J = 7.6 Hz), 7.07 (t, 1 H, J = 7.6 
Hz), 7.02–6.98 (m, 2 H), 2.49 (s, 3 H), 2.35 (s, 3 H); 13C NMR (CDCl3, 100 MHz) δ 135.8, 
127.8, 122.4, 121.2, 120.0, 119.3, 116.5, 112.2, 16.5, 9.8; HRMS (EI) m/z calcd for C10H11N 
145.0891, found 145.0909. The spectral data were consistent with those reported in the 
literature.
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5-(4-Fluorophenyl)furan-2-carboxylic acid (136). To a solution of 5-bromofuroic acid 
(405 mg, 2.12 mmol), (4-fluorophenyl)boronic acid (594 mg, 4.25 mmol) in DMF (2.8 mL) 
and K3PO4 (aq) (2.1 mL, 4.25 mmol) was added Pd(PPh3)4 (49.1 mg, 0.0425 mmol). The 
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reaction mixture was stirred under microwave irradiation at 150 
o
C for 30 min, quenched with 1 
M HCl (10 mL), extracted with ether, washed with brine, dried (Na2SO4), filtered and 
concentrated under reduced pressure to give a residue that was purified by chromatography on 
SiO2 (hexanes : EA = 4 : 1) to give 136 (350 mg, 80%) as a white solid: 
1
H NMR (CDCl3, 500 
MHz) δ 10.50 (br, 1 H), 7.79 (ddd, 2 H, J =2.0, 5.0, 7.0 Hz), 7.39 (d, 1 H, J = 3.5 Hz), 7.13 (tt, 2 
H, J = 2.5, 8.5 Hz), 6.72 (d, 1 H, J = 4.0 Hz). 
 
 
tert-Butyl (5-(4-fluorophenyl)furan-2-yl)carbamate (137). To a stirred solution of 136 
(270 mg, 1.31 mmol) in t-BuOH (3 mL) was added DPPA (0.282 mL, 1.31 mmol) and Et3N 
(0.368 mL, 2.62 mmol). The reaction mixture was refluxed behind the protective shield and 
under constant flow of argon for 10 h. The reaction was quenched by NaOH solution (1.0 M), 
extracted with ethyl acetate, washed with brine, dried (Na2SO4), filtered and concentrated under 
reduced pressure to give a residue that was purified by chromatography on SiO2 (hexanes : EA = 
15 : 1) to give 137 (231 mg, 64%) as a white solid: 
1
H NMR (CDCl3, 400 MHz) δ 7.54-7.49 (m, 
2 H), 7.06-7.00 (m, 2 H), 6.68 (br, 1 H), 6.53 (d, 1 H, J = 3.2 Hz), 6.12 (br, 1 H), 1.52 (s, 9 H). 
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(E)-4-((tert-Butoxycarbonyl)(5-(4-fluorophenyl)furan-2-yl)amino)-3-methylbut-2-en-
1-yl acetate (99). To a solution of 137 (231 mg, 0.833 mmol) in dry DMF (3.0 mL) at 0 
o
C was 
added NaH (50.0 mg, 1.25 mmol, 60 % in mineral oil) in 4 portions. The reaction mixture was 
stirred at 0 
o
C for 1 h. Then, (E)-4-bromo-3-methylbut-2-en-1-yl acetate
51
 (181 mg, 0.875 
mmol) was added dropwise over 5 min. The resulting solution was stirred at r.t. for 2 h, diluted 
with Et2O (10 mL), quenched with saturated aqueous NH4Cl (10 mL), extracted with Et2O (3 x 
10 mL), washed with water and brine, dried (Na2SO4), filtered and concentrated under reduced 
pressure. The crude product was purified by chromatography on SiO2 (hexanes : EA = 15 : 1) to 
give 99 (240 mg, 72%) as a yellow liquid: ATR-IR (neat) 2977, 2928, 1737, 1711, 1618, 1594, 
1553, 1497, 1392, 1366, 1228, 1156, 1057, 1020, 835, 779 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) δ 
7.55-7.52 (m, 2 H), 7.05 (tt, 2 H, J =2.0, 9.0 Hz), 6.50 (d, 1 H, J = 3.5 Hz), 6.06 (br, 1 H), 5.52-
5.48 (m, 1 H), 4.60 (d, 2 H, J = 7.0 Hz), 4.21 (s, 2 H), 1.98 (s, 3 H), 1.75 (s, 3 H), 1.47 (s, 9 H); 
13
C NMR (CDCl3, 125 MHz) δ 170.7, 162.3 (d, JCF = 245.0 Hz), 153.5, 147.7, 137.1, 127.0 (d, 
JCF = 3.8 Hz), 124.8 (d, JCF = 7.5 Hz), 120.3, 115.5 (d, JCF = 22.5 Hz), 105.6, 102.6, 81.4, 60.6, 
55.0, 28.0, 20.7, 14.2; HRMS (ESI) m/z calcd for C22H26NO5FNa ([M+Na]
+
) 426.1693, found 
426.1703. 
 
 
5-(4-Fluorophenyl)-3-methyl-1H-indole (100). To a solution of 99 (48 mg, 0.12 mmol) 
and P(OiPr)3 (4.9 mg, 0.024 mmol) in NMP (0.60 mL) was added Pd(PPh3)4 (6.8 mg, 0.0059 
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mmol). The reaction mixture was stirred under microwave irradiation at 180 
o
C for 20 min, 
quenched with ether and water, extracted with ether, washed with brine, dried (Na2SO4), filtered 
and concentrated under reduced pressure. The residue was purified by chromatography on SiO2 
(hexanes : EA = 16 : 1) to give 100 (18 mg, 66%) as a yellow solid: Mp 82.9–84.1 oC; ATR-IR 
(neat) 3413, 2923, 839, 814 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) δ 7.93 (br, 1 H), 7.72 (s, 1 H), 
7.61 (dd, 2 H, J = 5.5, 8.5 Hz), 7.39 (dd, 2 H, J = 8.0, 11.0 Hz), 7.13 (dd, 2 H, J = 8.5, 8.5 Hz), 
7.02 (s, 1 H), 2.37 (s, 3 H); 
13
C NMR (CDCl3, 125 MHz) δ 161.9 (d, JCF = 243.0 Hz), 138.8 (d, 
JCF = 3.0 Hz), 135.7, 131.8, 128.8 (d, JCF = 7.7 Hz), 128.8, 122.4, 121.6, 117.3, 115.4 (d, JCF = 
21.1 Hz), 112.2, 111.2, 9.7; HRMS (ESI) m/z calcd for C15H13NF ([M+H]
+
) 226.1032, found 
226.1018. 
 
 
tert-Butyl (5-(3-(trifluoromethyl)phenyl)furan-2-yl)carbamate (138). To a stirred 
solution of 5-(3-(trifluoromethyl)phenyl)furan-2-carboxylic acid (397 mg, 1.55 mmol) in t-
BuOH (3 mL) was added DPPA (0.334 mL, 1.55 mmol) and Et3N (0.435 mL, 3.10 mmol). The 
reaction mixture was refluxed behind the protective shield and under constant flow of argon for 
10 h. The reaction was quenched by NaOH solution (1.0 M), extracted with ethyl acetate, 
washed with brine, dried (Na2SO4), filtered and concentrated under reduced pressure to give a 
residue that was purified by chromatography on SiO2 (hexanes : EA = 15 : 1) to give 138 (410 
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mg, 81%) as a white solid: 
1
H NMR (CDCl3, 300 MHz) δ 7.77 (s, 1 H), 7.70-7.66 (m, 1 H), 7.44-
7.42 (m, 2 H), 6.92 (br, 1 H), 6.69 (d, 1 H, J = 3.3 Hz), 6.16 (br, 1 H), 1.54 (s, 9 H). 
 
 
((E)-4-((tert-Butoxycarbonyl)(5-(3-(trifluoromethyl)phenyl)furan-2-yl)amino)-3-
methylbut-2-en-1-yl acetate (101). To a solution of 138 (362 mg, 1.11 mmol) in dry DMF (4.0 
mL) at 0 
o
C was added NaH (66.3 mg, 1.66 mmol, 60 % in mineral oil) in 4 portions. The 
reaction mixture was stirred at 0 
o
C for 1 h. Then, (E)-4-bromo-3-methylbut-2-en-1-yl 
acetate
51
 (240 mg, 1.16 mmol) was added dropwise over 5 min. The resulting solution was 
stirred at r.t. for 2 h, diluted with Et2O (10 mL), quenched with saturated aqueous NH4Cl (10 
mL), extracted with Et2O (3 x 10 mL), washed with water and brine, dried (Na2SO4), filtered and 
concentrated under reduced pressure. The crude product was purified by chromatography on 
SiO2 (hexanes : EA = 15 : 1) to give 101 (333 mg, 66%) as a yellow liquid: ATR-IR (neat) 2978, 
2930, 1737, 1713, 1610, 1592, 1551, 1452, 1392, 1366, 1333, 1267, 1230, 1159, 1124, 1098, 
1075, 1060, 1021, 857, 796, 783, 697 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 7.79 (s, 1 H), 7.74-
7.72 (m, 1 H), 7.48-7.46 (m, 2 H), 6.68 (d, 1 H, J = 3.6 Hz), 6.12 (br, 1 H), 5.51 (qt, 1 H, J = 1.2, 
6.8 Hz), 4.60 (d, 2 H, J = 6.8 Hz), 4.24 (s, 2 H), 1.98 (s, 3 H), 1.76 (s, 3 H), 1.48 (s, 9 H); 
13
C 
NMR (CDCl3, 100 MHz) δ 170.6, 153.2, 148.5, 147.0, 136.9, 131.3, 131.0 (q, JCF = 32.2 Hz), 
129.0, 126.0, 124.9 (q, JCF = 271.0 Hz), 123.2 (q, JCF = 3.6 Hz), 120.5, 119.6 (q, JCF = 3.8 Hz), 
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107.6, 102.4, 81.6, 60.6, 54.7, 27.9, 20.6, 14.2; HRMS (ESI) m/z calcd for C23H26NO5F3Na 
([M+Na]
+
) 476.1661, found 476.1679. 
 
 
3-Methyl-5-(3-(trifluoromethyl)phenyl)-1H-indole (102). To a solution of 101 (47 mg, 
0.10 mmol) and P(OiPr)3 (4.3 mg, 0.021 mmol) in NMP (0.51 mL) was added Pd(PPh3)4 (6.0 
mg, 0.0051 mmol). The reaction mixture was stirred under microwave irradiation at 180 
o
C for 
20 min, quenched with ether and water, extracted with ether, washed with brine, dried (Na2SO4), 
filtered and concentrated under reduced pressure. The residue was purified by chromatography 
on SiO2 (hexanes : EA = 16 : 1) to give 102 (12 mg, 41%) as a yellow liquid: ATR-IR (neat) 
3418, 2921, 1331, 1070, 792 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) δ 7.96 (br, 1 H), 7.91 (s, 1 H), 
7.85 (dd, 1 H, J = 1.5, 4.0 Hz), 7.78 (s, 1 H), 7.56-7.55 (m, 2 H), 7.44 (s, 2 H), 7.04 (d, 1 H, J = 
1.0 Hz), 2.39 (d, 3 H, J = 1.0 Hz); 
13
C NMR (CDCl3, 125 MHz) δ 143.5, 136,1, 132,3, 131.0 (q, 
JCF = 31.0 Hz), 130.6, 129.0, 128.9, 124.4 (q, JCF = 271.0 Hz), 124.0 (q, JCF = 3.8 Hz), 122.9 (q, 
JCF = 3.8 Hz), 122.6, 121.5, 117.6, 112.3, 111.4, 9.7; HRMS (EI) m/z calcd for C16H12NF3 
275.0922, found 275.0900. 
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5-(3,5-Bis(trifluoromethyl)phenyl)furan-2-carboxylic acid (139). To a solution of 5-
bromofuroic acid (108 mg, 0.567 mmol), (3,5-bis(trifluoromethyl)phenyl)boronic acid (293 
mg, 1.13 mmol) in DMF (1.0 mL) and K3PO4 (aq) (0.6 mL, 1.13 mmol) was added Pd(PPh3)4 
(13.1 mg, 0.0113 mmol). The reaction mixture was stirred under microwave irradiation at 150 
o
C 
for 30 min, quenched with 1 M HCl (10 mL), extracted with ether, washed with brine, dried 
(Na2SO4), filtered and concentrated under reduced pressure to give a residue that was purified by 
chromatography on SiO2 (hexanes : EA = 4 : 1) to give 139 (177 mg, 96%) as a white solid: 
1
H 
NMR (CDCl3, 500 MHz) δ 11.65 (br, 1 H), 8.19 (s, 2 H), 7.85 (s, 1 H), 7.42 (d, 1 H, J = 3.5 Hz), 
6.98 (d, 1 H, J = 3.5 Hz). 
 
 
tert-Butyl (5-(3,5-bis(trifluoromethyl)phenyl)furan-2-yl)carbamate (140). To a stirred 
solution of 139 (177 mg, 5.46 mmol) in t-BuOH (2 mL) was added DPPA (0.118 mL, 5.47 
mmol) and Et3N (0.154 mL, 1.09 mmol). The reaction mixture was refluxed behind the 
protective shield and under constant flow of argon for 10 h. The reaction was quenched by 
NaOH solution (1.0 M), extracted with ethyl acetate, washed with brine, dried (Na2SO4), filtered 
and concentrated under reduced pressure to give a residue that was purified by chromatography 
on SiO2 (hexanes : EA = 15 : 1) to give 140 (148 mg, 68%) as a white solid: 
1
H NMR (CDCl3, 
500 MHz) δ 7.85 (s, 2 H), 7.60 (s, 1 H), 7.48 (br, 1 H), 6.75 (d, 1 H, J = 3.5 Hz), 6.19 (br, 1 H), 
1.54 (s, 9 H). 
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(E)-4-((5-(3,5-Bis(trifluoromethyl)phenyl)furan-2-yl)(tert-butoxycarbonyl)amino)-3-
methylbut-2-en-1-yl acetate (103). To a solution of 139 (148 mg, 0.374 mmol) in dry DMF (2.0 
mL) at 0 
o
C was added NaH (22.4 mg, 0.561 mmol, 60 % in mineral oil) in 4 portions. The 
reaction mixture was stirred at 0 
o
C for 1 h. Then, (E)-4-bromo-3-methylbut-2-en-1-yl 
acetate
51
 (81.3 mg, 0.393 mmol) was added dropwise over 5 min. The resulting solution was 
stirred at r.t. for 2 h, diluted with Et2O (10 mL), quenched with saturated aqueous NH4Cl (10 
mL), extracted with Et2O (3 x 10 mL), washed with water and brine, dried (Na2SO4), filtered and 
concentrated under reduced pressure. The crude product was purified by chromatography on 
SiO2 (hexanes : EA = 15 : 1) to give 103 (170 mg, 87%) as a yellow solid: Mp 70.3–71.8 
o
C; 
ATR-IR (neat) 2980, 2928, 2855, 1743, 1720, 1622, 1607, 1549, 1454, 1377, 1370, 1279, 1232, 
1172, 1135, 1023, 952, 891, 856, 844, 788, 703, 682 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) δ 7.92 (s, 
2 H), 7.66 (s, 1 H), 6.79 (d, 1 H, J = 3.5 Hz), 6.17 (br, 1 H), 5.50 (qt, 1 H, J = 1.0, 7.0 Hz), 4.60 
(d, 2 H, J = 7.0 Hz), 4.26 (s, 2 H), 1.96 (s, 3 H), 1.75 (s, 3 H), 1.48 (s, 9 H); 
13
C NMR (CDCl3, 
100 MHz) δ 170.8, 153.0, 149.4, 145.4, 136.8, 132.4, 132.1 (q, JCF = 33.0 Hz), 123.2 (q, JCF = 
270.0 Hz), 122.6 (q, JCF = 3.8 Hz), 120.6, 119.8 (sp, JCF = 3.8 Hz), 109.4, 102.4, 82.0, 60.6, 54.6, 
28.0, 20.7, 14.3; HRMS (ESI) m/z calcd for C24H26NO5F6 ([M+H]
+
) 522.1715, found 522.1694. 
 
47 
   
 
 
 
5-(3,3-Dimethylbut-1-yn-1-yl)-3-methyl-1H-indole (104). To a solution of 103 (88 mg, 
0.17 mmol) and P(OiPr)3 (7.1 mg, 0.034 mmol) in NMP (0.85 mL) was added Pd(PPh3)4 (9.8 
mg, 0.0085 mmol). The reaction mixture was stirred under microwave irradiation at 180 
o
C for 
20 min, quenched with ether and water, extracted with ether, washed with brine, dried (Na2SO4), 
filtered and concentrated under reduced pressure. The residue was purified by chromatography 
on SiO2 (hexanes : EA = 16 : 1) to give 104 (28 mg, 48%) as a yellow solid: 109.2–110.8 
o
C; 
ATR-IR (neat) 3420, 2926, 1376, 1277, 1172, 1131, 798, 684 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) 
δ 8.08 (s, 1 H), 8.02 (br, 1 H), 7.80 (s, 1 H), 7.79 (d, 1 H, J = 0.5 Hz), 7.46 (d, 1 H, J = 8.0 Hz), 
7.44 (dd, 1 H, J = 1.5, 8.5 Hz), 7.06 (d, 1 H, J = 1.0 Hz), 2.41 (d, 3 H, J = 1.0 Hz); 
13
C NMR 
(CDCl3,125 MHz) δ 144.8, 136.4, 131.8 (q, JCF = 32.5 Hz), 129.7, 129.0, 127.3(q, JCF = 2.9 Hz), 
123.6 (q, JCF = 270.0 Hz), 122.9, 121.3, 119.7 (sp, JCF = 3.8 Hz); 117.8, 112.5, 111.7, 9.7; 
HRMS (EI) m/z calcd for C17H11NF6 343.0796, found 343.0815. 
 
 
tert-Butyl (5-phenylfuran-2-yl)carbamate (141). To a stirred solution of 5-
phenylfuran-2-carboxylic acid (366 mg, 1.94 mmol) in t-BuOH (3 mL) was added DPPA 
(0.418 mL, 1.94 mmol) and Et3N (0.546 mL, 3.89 mmol). The reaction mixture was refluxed 
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behind the protective shield and under constant flow of argon for 10 h. The reaction was 
quenched by NaOH solution (1.0 M), extracted with ethyl acetate, washed with brine, dried 
(Na2SO4), filtered and concentrated under reduced pressure to give a residue that was purified by 
chromatography on SiO2 (hexanes : EA = 15 : 1) to give 141 (320 mg, 64%) as a white solid: 
1
H 
NMR (CDCl3, 300 MHz) δ 7.54 (d, 2 H, J =7.5 Hz), 7.42-7.32 (m, 3 H), 6.72 (br, 1 H), 6.60 (d, 
1 H, J = 3.3 Hz), 6.13 (br, 1 H), 1.53 (s, 9 H). 
 
 
(E)-4-((tert-Butoxycarbonyl)(5-phenylfuran-2-yl)amino)-3-methylbut-2-en-1-yl 
acetate (105). To a solution of 141 (320 mg, 1.24 mmol) in dry DMF (3.0 mL) at 0 
o
C was 
added NaH (74.2 mg, 1.85 mmol, 60 % in mineral oil) in 4 portions. The reaction mixture was 
stirred at 0 
o
C for 1 h. Then, (E)-4-bromo-3-methylbut-2-en-1-yl acetate
51
 (269 mg, 1.30 
mmol) was added dropwise over 5 min. The resulting solution was stirred at r.t. for 2 h, diluted 
with Et2O (10 mL), quenched with saturated aqueous NH4Cl (10 mL), extracted with Et2O (3 x 
10 mL), washed with water and brine, dried (Na2SO4), filtered and concentrated under reduced 
pressure. The crude product was purified by chromatography on SiO2 (hexanes : EA = 15 : 1) to 
give 105 (328 mg, 69%) as a pale yellow liquid: ATR-IR (neat) 2977, 2930, 1735, 1709, 1597, 
1549, 1446, 1390, 1366, 1228, 1156, 1060, 1020, 857, 759, 692 cm
-1
;
 1
H NMR (CDCl3, 500 
MHz) δ 7.56 (d, 2 H, J = 7.5 Hz), 7.33 (t, 2 H, J = 7.5 Hz), 7.19 (t, 1 H, J = 7.5 Hz), 6.57 (d, 1 
H, J = 3.5 Hz), 6.07 (br, 1 H), 5.51 (qt, 1 H, J = 1.0, 7.0 Hz), 4.59 (d, 2 H, J = 7.0 Hz), 4.22 (s, 2 
49 
   
 
 
H), 1.95 (s, 3 H), 1.74 (s, 3 H), 1.46 (s, 9 H); 
13
C NMR (CDCl3, 125 MHz) δ 170.8, 153.4, 147.6, 
137.0, 130.5, 129.2, 128.4, 126.8, 123.0, 120.3, 114.6, 106.0, 81.3, 60.6, 54.8, 28.0, 20.6, 14.2; 
HRMS (ESI) m/z calcd for C22H27NO5Na ([M+Na]
+
) 408.1787, found 408.1776. 
 
 
3-Methyl-5-phenyl-1H-indole (106). To a solution of 105 (57 mg, 0.15 mmol) and 
P(OiPr)3 (6.1 mg, 0.029 mmol) in NMP (0.73 mL) was added Pd(PPh3)4 (8.5 mg, 0.0073 mmol). 
The reaction mixture was stirred under microwave irradiation at 180 
o
C for 20 min, quenched 
with ether and water, extracted with ether, washed with brine, dried (Na2SO4), filtered and 
concentrated under reduced pressure. The residue was purified by chromatography on SiO2 
(hexanes : EA = 16 : 1) to give 106 (24 mg, 77%) as a yellow liquid: ATR-IR (neat) 3416, 3062, 
2921, 762 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) δ 7.92 (br, 1 H), 7.78 (dd, 1 H, J = 1.0, 1.5 Hz), 
7.68 (d, 1 H, J = 1.5 Hz), 7.67 (d, 1 H, J = 1.0 Hz), 7.46-7.40 (m, 4 H), 7.32 (tt, 1 H, J = 1.0, 7.5 
Hz), 7.01 (d, 1 H, J = 1.0 Hz), 2.38 (d, 3 H, J = 1.0 Hz); 
13
C NMR (CDCl3, 125 MHz) δ 142.7, 
135.7, 132.8, 128.8, 128.6, 127.4, 126.2, 122.2, 121.7, 117.4, 112.2, 111.1, 9.7; HRMS (EI) m/z 
calcd for C15H13N 207.1048, found 207.1065. 
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5-(m-Tolyl)furan-2-carboxylic acid (120). To a solution of 5-bromofuroic acid (210 
mg, 1.10 mmol), m-tolylboronic acid (299 mg, 2.20 mmol) in DMF (1.8 mL) and K3PO4 (aq) 
(1.0 mL, 2.20 mmol) was added Pd(PPh3)4 (22.0 mg, 0.0254 mmol). The reaction mixture was 
stirred under microwave irradiation at 150 
o
C for 30 min, quenched with 1 M HCl (10 mL), 
extracted with ether, washed with brine, dried (Na2SO4), filtered and concentrated under reduced 
pressure to give a residue that was purified by chromatography on SiO2 (hexanes : EA = 4 : 1) to 
give 120 (222 mg, 99%) as a white solid: 
1
H NMR (CDCl3, 300 MHz) δ 7.65 (s, 1 H), 7.61 (d, 1 
H, J = 7.8 Hz), 7.41 (d, 1 H, J = 3.6 Hz), 7.33 (t, 1 H, J = 7.8 Hz), 7.19 (d, 1 H, J = 7.5 Hz), 6.78 
(d, 1 H, J = 4.8 Hz). 
 
 
tert-Butyl (5-(m-tolyl)furan-2-yl)carbamate (121). To a stirred solution of 120 (222 
mg, 1.10 mmol) in t-BuOH (3 mL) was added DPPA (0.237 mL, 1.10 mmol) and Et3N (0.309 
mL, 2.20 mmol). The reaction mixture was refluxed behind the protective shield and under 
constant flow of argon for 10 h. The reaction was quenched by NaOH solution (1.0 M), extracted 
with ethyl acetate, washed with brine, dried (Na2SO4), filtered and concentrated under reduced 
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pressure to give a residue that was purified by chromatography on SiO2 (hexanes : EA = 15 : 1) 
to give 121 (194 mg, 65%) as a white solid: 
1
H NMR (CDCl3, 400 MHz) δ 7.37 (d, 1 H, J = 4.4 
Hz), 7.34 (s, 1 H), 7.22 (d, 1 H, J = 7.6 Hz), 7.02 (d, 1 H, J = 7.6 Hz), 6.72 (br, 1 H), 6.58 (d, 1 
H, J = 3.2 Hz), 6.12 (br, 1 H), 2.36 (s, 3 H), 1.52 (s, 9 H). 
 
 
(E)-4-((tert-Butoxycarbonyl)(5-(m-tolyl)furan-2-yl)amino)-3-methylbut-2-en-1-yl 
acetate (107). To a solution of 121 (170 mg, 0.622 mmol) in dry DMF (2.0 mL) at 0 
o
C was 
added NaH (37.3 mg, 1.25 mmol, 60 % in mineral oil) in 4 portions. The reaction mixture was 
stirred at 0 
o
C for 1 h. Then, (E)-4-bromo-3-methylbut-2-en-1-yl acetate
51
 (135 mg, 0.653 
mmol) was added dropwise over 5 min. The resulting solution was stirred at r.t. for 2 h, diluted 
with Et2O (10 mL), quenched with saturated aqueous NH4Cl (10 mL), extracted with Et2O (3 x 
10 mL), washed with water and brine, dried (Na2SO4), filtered and concentrated under reduced 
pressure. The crude product was purified by chromatography on SiO2 (hexanes : EA = 15 : 1) to 
give 107 (167 mg, 67%) as a yellow liquid: ATR-IR (neat) 2975, 2926, 1735, 1709, 1603, 1549, 
1366, 1390, 1228, 1158, 1021, 1060, 949, 857, 779, 692 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 
7.38-7.36 (m, 2 H), 7.22 (t, 1 H, J = 7.6 Hz), 7.02 (d, 1 H, J =7.2 Hz), 6.55 (d, 1 H, J = 3.6 Hz), 
6.07 (br, 1 H), 5.50 (qt, 1 H, J = 1.6, 7.2 Hz), 4.59 (d, 2 H, J = 7.2 Hz), 4.22 (s, 2 H); 2.35 (s, 3 
H), 1.95 (s, 3 H), 1.75 (s, 3 H), 1.46 (s, 9 H); 
13
C NMR (CDCl3, 100 MHz) δ 170.6, 153.4, 148.8, 
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147.4, 138.0, 137.0, 128.4, 127.6, 123.6, 120.3, 120.2, 105.8, 102.5, 81.3, 60.6, 54.8, 27.9, 21.3, 
20.6, 14.2; HRMS (ESI) m/z calcd for C23H29NO5Na ([M+Na]
+
) 422.1943, found 422.1951. 
 
 
3-Methyl-5-(m-tolyl)-1H-indole (108). To a solution of 107 (34 mg, 0.085 mmol) and 
P(OiPr)3 (3.5 mg, 0.017 mmol) in NMP (0.43 mL) was added Pd(PPh3)4 (4.9 mg, 0.0043 mmol). 
The reaction mixture was stirred under microwave irradiation at 180 
o
C for 20 min, quenched 
with ether and water, extracted with ether, washed with brine, dried (Na2SO4), filtered and 
concentrated under reduced pressure. The residue was purified by chromatography on SiO2 
(hexanes : EA = 16 : 1) to give 108 (16 mg, 87%) as a yellow liquid: ATR-IR (neat) 3417, 3025, 
2921, 785 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) δ 7.91 (br, 1 H), 7.77 (s, 1 H), 7.49-7.39 (m, 4 H), 
7.34 (t, 1 H, J = 8.0 Hz), 7.14 (d, 1 H, J = 8.0 Hz), 7.00 (s, 1 H), 2.44 (s, 3 H), 2.38 (d, 3 H, J = 
0.5 Hz); 
13
C NMR (CDCl3,125 MHz) δ 142.7, 138.1, 135.7, 132.9, 128.7, 128.5, 128.2, 127.0, 
124.5, 122.2, 121.8, 117.4, 112.1, 111.1, 21.6, 9.7; HRMS (EI) m/z calcd for C16H15N 221.1204, 
found 221.1216. 
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5-(4-Methoxyphenyl)furan-2-carboxylic acid (142). To a solution of 5-bromofuroic 
acid (309 mg, 1.62 mmol), (4-methoxyphenyl)boronic acid (492 mg, 3.24 mmol) in DMF (1.8 
mL) and K3PO4 (aq) (1.2 mL, 3.24 mmol) was added Pd(PPh3)4 (37.4 mg, 0.0324 mmol). The 
reaction mixture was stirred under microwave irradiation at 150 
o
C for 30 min, quenched with 1 
M HCl (10 mL), extracted with ether, washed with brine, dried (Na2SO4), filtered and 
concentrated under reduced pressure to give a residue that was purified by chromatography on 
SiO2 (hexanes : EA = 4 : 1) to give 142 (350 mg, 99%) as a white solid: 
1
H NMR (CDCl3, 300 
MHz) δ 11.29 (br, 1 H), 7.73 (d, 2 H, J = 9.0 Hz), 7.35 (d, 1 H, J = 3.6 Hz), 6.94 (d, 2 H, J = 9.0 
Hz), 6.63 (d, 1 H, J = 3.6 Hz), 3.84 (s, 3 H). The spectral data were consistent with those 
reported in the literature.
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tert-Butyl (5-(4-methoxyphenyl)furan-2-yl)carbamate (143). To a stirred solution of 
142 (350 mg, 1.60 mmol) in t-BuOH (3 mL) was added DPPA (0.346 mL, 1.60 mmol) and Et3N 
(0.451 mL, 3.21 mmol). The reaction mixture was refluxed behind the protective shield and 
under constant flow of argon for 10 h. The reaction was quenched by NaOH solution (1.0 M), 
extracted with ethyl acetate, washed with brine, dried (Na2SO4), filtered and concentrated under 
reduced pressure to give a residue that was purified by chromatography on SiO2 (hexanes : EA = 
15 : 1) to give 143 (305 mg, 66%) as a white solid: 
1
H NMR (CDCl3, 400 MHz) δ 7.48 (td, 2 H, 
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J = 2.4, 8.8 Hz), 6.89 (td, 2 H, J = 2.4, 8.8 Hz), 6.80 (br, 1 H), 6.46 (d, 1 H, J = 3.2 Hz), 6.11 (br, 
1 H), 3.81 (s, 3 H), 1.51 (s, 9 H). 
 
 
(E)-4-((tert-Butoxycarbonyl)(5-(4-methoxyphenyl)furan-2-yl)amino)-3-methylbut-2-
en-1-yl acetate (109). To a solution of 143 (371 mg, 1.28 mmol) in dry DMF (3.0 mL) at 0 
o
C 
was added NaH (76.8 mg, 1.92 mmol, 60 % in mineral oil) in 4 portions. The reaction mixture 
was stirred at 0 
o
C for 1 h. Then, (E)-4-bromo-3-methylbut-2-en-1-yl acetate
51
 (279 mg, 1.34 
mmol) was added dropwise over 5 min. The resulting solution was stirred at r.t. for 2 h, diluted 
with Et2O (10 mL), quenched with saturated aqueous NH4Cl (10 mL), extracted with Et2O (3 x 
10 mL), washed with water and brine, dried (Na2SO4), filtered and concentrated under reduced 
pressure. The crude product was purified by chromatography on SiO2 (hexanes : EA = 15 : 1) to 
give 109 (356 mg, 67%) as a yellow liquid: ATR-IR (neat) 2973, 2928, 1735, 1711, 1620, 1605, 
1581, 1554, 1498, 1456, 1441, 1392, 1366, 1292, 1273, 1247, 1230, 1159, 1060, 1021, 951, 831, 
779 cm
-1
;
 1
H NMR (CDCl3, 500 MHz) δ 7.51 (td, 2 H, J = 2.5, 9.5 Hz), 6.90 (td, 2 H, J = 2.5, 9.5 
Hz), 6.43 (d, 1 H, J = 3.0 Hz), 6.04 (br, 1 H), 5.50 (qt, 1 H, J = 1.5, 7.0 Hz), 4.60 (d, 2 H, J = 7.0 
Hz), 4.20 (s, 2 H), 3.82 (s, 3 H), 1.99 (s, 3 H), 1.75 (s, 3 H), 1.47 (s, 9 H); 
13
C NMR (CDCl3, 125 
MHz) δ 170.9, 158.8, 153.8, 149.1, 147.1, 137.3, 124.7, 123.9, 120.4, 114.1, 104.4, 102.8, 81.4, 
60.8, 55.3, 55.2, 28.2, 20.9, 14.4; HRMS (ESI) m/z calcd for C23H29NO6Na ([M+Na]
+
)438.1893, 
found 438.1895. 
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5-(4-Methoxyphenyl)-3-methyl-1H-indole (110). To a solution of 109 (53 mg, 0.13 
mmol) and P(OiPr)3 (5.3 mg, 0.025 mmol) in NMP (0.64 mL) was added Pd(PPh3)4 (7.4 mg, 
0.0063 mmol). The reaction mixture was stirred under microwave irradiation at 180 
o
C for 20 
min, quenched with ether and water, extracted with ether, washed with brine, dried (Na2SO4), 
filtered and concentrated under reduced pressure. The residue was purified by chromatography 
on SiO2 (hexanes : EA = 16 : 1) to give 110 (19 mg, 64%) as a yellow solid: Mp 130.2–133.0 
o
C; 
ATR-IR (neat) 3410, 2919, 1240 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) δ 7.89 (br, 1 H), 7.73-7.72 
(m, 1 H), 7.60 (td, 2 H, J = 2.5, 9.0 Hz), 7.40 (dd, 1 H, J = 2.0, 8.0 Hz), 7.38 (dd, 1 H, J = 0.5, 
8.5 Hz), 7.01–6.98 (m, 3 H), 3.86 (s, 3 H), 2.37 (d, 3 H, J = 1.0 Hz); 13C NMR (CDCl3,100 
MHz) δ 158.4, 135.5, 135.4, 132.5, 128.8, 128.3, 122.2, 121.5, 116.9, 114.1, 112.0, 111.1, 53.4, 
9.7; HRMS (ESI) m/z calcd for C16H16NO ([M+H]
+
) 238.1232, found 238.1257. 
 
 
Methyl 5-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)furan-2-carboxylate (144). To a 
solution of methyl 5-(hydroxymethyl)furan-2-carboxylate
60
 (18 mg, 0.12 mmol) in CH2Cl2 (2 
mL) was added DHP (0.016 mL, 0.17 mmol) and PPTS (2.9 mg, 0.012 mmol). The reaction 
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mixture was stirred at r.t. for 4 h, quenched with 1 N HCl (10 mL) and extracted with ethyl 
acetate, dried (Na2SO4), filtered and concentrated under reduced pressure to give a residue that 
was purified by chromatography on SiO2 to give 144 (25.3 mg, 91%) as a colorless liquid: ATR-
IR (neat) 3006, 2930, 2855, 2807, 1720, 1618, 1603, 1526, 1409, 1389, 1288, 1208, 1135, 1072, 
1020, 902, 872, 760, 697 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 7.14(d, 1 H, J = 3.6 Hz), 6.44 (d, 1 
H, J = 3.6 Hz), 4.72 (t, 1 H, J = 3.2 Hz), 4.71 (d, 1 H, J = 13.2 Hz), 4.53 (d, 1 H, J = 13.2 Hz), 
3.89 (s, 3 H), 3.87 (ddd, 1 H, J = 3.2, 8.8, 12.0 Hz), 3.57-3.52 (m, 1 H), 1.87-1.78 (m, 1 H), 
1.76-1.69 (m, 1 H), 1.66-1.59 (m, 2 H), 1.55-1.51 (m, 2 H); 
13
C NMR (CDCl3, 125 MHz) δ 
159.1, 156.3, 144.3, 118.8, 110.8, 97.9, 62.0, 60.9, 51.9, 30.3, 25.3, 19.0; HRMS (ESI) m/z calcd 
for C12H16O5Na ([M+Na]
+
) 263.0895, found 263.0880. 
 
 
5-(((Tetrahydro-2H-pyran-2-yl)oxy)methyl)furan-2-carboxylic acid (145). To a 
solution of 144 (204 mg, 0.849 mmol) in THF (2 mL) was added LiOH (71.3 mg, 1.70 mmol). 
The reaction mixture was stirred at r.t. for 4 h, quenched with 1 N HCl (10 mL) and extracted 
with ethyl acetate, dried (Na2SO4), filtered and concentrated under reduced pressure to give 145 
(165 mg, 86%) as a white semi-solid:  ATR-IR (neat) 3055, 2934, 2855, 1689, 1594, 1526, 1266, 
1200, 1120, 1018, 964, 902, 811, 734 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 9.83 (br, 1 H), 7.27 
(d, 1 H, J = 3.0 Hz), 6.48 (d, 1 H, J = 3.5 Hz), 4.75 (t, 1 H, J = 3.2 Hz), 4.74 (d, 1 H, J = 13.5 
Hz), 4.59 (d, 1 H, J = 13.5 Hz), 3.88 (ddd, 1 H, J = 3.2, 9.0, 12.0 Hz), 3.57-3.55 (m, 1 H), 1.86-
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1.64 (m, 6 H).; 
13
C NMR (CDCl3, 125 MHz) δ 163.0, 157.4, 143.5, 120.8, 111.0, 97.9, 62.0, 
60.9, 30.2, 25.3, 18.9; HRMS (ESI) m/z calcd for C11H13O5 ([M]
+
) 225.0763, found 225.0773. 
 
 
tert-Butyl (5-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)furan-2-yl)carbamate (146). 
To a stirred solution of 145 (124 mg, 0.549 mmol) in t-BuOH (5 mL) was added DPPA (0.118 
mL, 0.549 mmol) and Et3N (0.154 mL, 1.10 mmol). The reaction mixture was refluxed behind 
the protective shield and under constant flow of argon for 12 h. The reaction was quenched by 
NaOH solution (1.0 M), extracted with ethyl acetate, washed with brine, dried (Na2SO4), filtered 
and concentrated under reduced pressure to give a residue that was purified by chromatography 
on SiO2 (hexanes : EA = 15 : 1) to give 146 (70.1 mg, 43%) as a white solid: 
1
H NMR (CDCl3, 
400 MHz) δ 6.78 (br, 1 H), 6.27 (d, 1 H, J = 3.2 Hz), 5.97 (br, 1 H), 4.69 (t, 1 H, J = 3.6 Hz), 
4.55 (d, 1 H, J = 12.8 Hz), 4.39 (d, 1 H, J = 12.8 Hz), 3.87 (ddd, 1 H, J = 3.2, 9.2, 12.0 Hz), 
3.51 (td, 1 H, J = 5.2, 11.2 Hz), 1.85-1.52 (m, 6 H), 1.49 (s, 9 H). 
 
 
(E)-4-((tert-Butoxycarbonyl)(5-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)furan-2-
yl)amino)-3-methylbut-2-en-1-yl acetate (111). To a solution of 146 (298 mg, 1.00 mmol) in 
dry DMF (2.0 mL) at 0 
o
C was added NaH (60.0 mg, 1.50 mmol, 60 % in mineral oil) in 4 
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portions. The reaction mixture was stirred at 0 
o
C for 1 h. Then, (E)-4-bromo-3-methylbut-2-
en-1-yl acetate
51
 (218 mg, 1.05 mmol) was added dropwise over 5 min. The resulting solution 
was stirred at r.t. for 2 h, diluted with Et2O (10 mL), quenched with saturated aqueous NH4Cl (10 
mL), extracted with Et2O (3 x 10 mL), washed with water and brine, dried (Na2SO4), filtered and 
concentrated under reduced pressure. The crude product was purified by chromatography on 
SiO2 (hexanes : EA = 15 : 1) to give 111 (340 mg, 80%) as a yellow liquid: ATR-IR (neat) 2973, 
2939, 2868, 1737, 1713, 1620, 1562, 1454, 1441, 1390, 1366, 1228, 1200, 1159, 1133, 1116, 
1016, 964, 904, 869, 816, 785 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 6.25 (d, 1 H, J = 3.2 Hz), 
5.93 (br, 1 H), 5.43 (qt, 1 H, J = 0.8, 6.4 Hz), 4.69 (t, 1 H, J = 3.2 Hz), 4.57 (d, 1 H, J = 13.2 Hz), 
4.56 (d, 2 H, J = 6.8 Hz), 4.42 (d, 1 H, J = 13.2 Hz), 4.13 (s, 2 H), 3.88 (ddd, 1 H, J = 2.8, 8.4, 
11.2 Hz), 3.53 (td, 1 H, J = 4.4, 10.8 Hz), 2.02 (s, 3 H), 1.86-1.49 (m, 9 H), 1.44 (s, 9 H); 
13
C 
NMR (CDCl3, 125 MHz) δ 170.6, 153.5, 148.0,146.7, 137.0, 120.2, 110.4, 101.4, 96.6, 81.1, 
61.6, 60.6, 60.4, 54.8, 30.2, 27.9, 25.2, 20.7, 18.9, 14.2; HRMS (ESI) m/z calcd for 
C22H33NO7Na ([M+Na]
+
) 446.2155, found 446.2133. 
 
 
3-Methyl-5-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-1H-indole (112). To a solution 
of 111 (63 mg, 0.15 mmol) and P(OiPr)3 (6.2 mg, 0.030 mmol) in NMP (0.75 mL) was added 
Pd(PPh3)4 (8.6 mg, 0.0074 mmol). The reaction mixture was stirred under microwave irradiation 
at 180 
o
C for 20 min, quenched with ether and water, extracted with ether, washed with brine, 
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dried (Na2SO4), filtered and concentrated under reduced pressure. The residue was purified by 
chromatography on SiO2 (hexanes : EA = 16 : 1) to give 112 (22 mg, 59%) as a pale yellow 
liquid: ATR-IR (neat) 3411, 2930, 1116, 1074, 1023, 794 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) δ 
7.91 (br, 1 H), 7.58 (s, 1 H), 7.32 (d, 1 H, J =  8.0 Hz), 7.22 (dd, 1 H, J = 1.0, 8.5 Hz), 6.97 (s, 1 
H), 4.90 (d, 1 H, J = 11.0 Hz), 4.75 (t, 1 H, J = 3.5 Hz), 4.62 (d, 1 H, 11.5 Hz), 3.99 (ddd, 1 H, J 
= 3.0, 9.0, 12.0 Hz), 3.58 (td, 1 H, J = 5.0 , 11.0 Hz), 2.33 (d, 3 H, J = 0.5 Hz), 1.90-1.84 (m, 1 
H), 1.76-1.70 (m, 1 H), 1.67-1.51 (m, 4 H); 
13
C NMR (CDCl3,125 MHz) δ 135.9, 128.8, 128.3, 
122.8, 122.0, 119.0, 111.8, 110.8, 97.2, 62.2, 30.7, 25.6, 19.5, 9.6; HRMS (ESI) m/z calcd for 
C15H19NO2Na ([M+Na]
+
) 268.1313, found 268.1335. 
 
 
Methyl 5-(3,3-dimethylbut-1-yn-1-yl)furan-2-carboxylate (147). To a stirred solution 
of methyl 5-bromofuran-2-carboxylate (370 mg, 1.80 mmol), CuI (34.4 mg, 0.180 mmol) and 
Pd(PPh3)2Cl2 (27.7 mg, 0.0902 mmol) in 3 mL triethylamine at room temperature was slowly 
added 3,3-dimethylbutyne (0.445 mL, 3.61 mmol) at r.t.. The reaction mixture was stirred at r.t. 
for 24 h, filtered by celite and concentrated under reduced pressure to give a residue that was 
purified by chromatography on SiO2 (hexanes : EA = 12 : 1) to give 147 (369 mg, 99%) as a 
white solid.: Mp 72.7–74.3 oC; ATR-IR (neat) 2964, 2220, 1713, 1582, 1508, 1439, 1364, 1297, 
1212, 1129, 1023, 1021, 986, 923, 811, 760 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 7.12 (d, 1 H, J 
= 3.6 Hz), 6.50 (d, 1 H, J = 3.6 Hz), 3.88 (s, 3 H), 1.30 (s, 9 H); ); 
13
C NMR (CDCl3, 125 MHz) 
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δ 158.5, 143.5, 141.0, 118.8, 115.2, 104.6, 69.0, 52.0, 30.4, 28.1; HRMS (ESI) m/z calcd for 
C12H15O3 ([M+H]
+
) 207.1021, found 207.1026.  
 
 
5-(3,3-Dimethylbut-1-yn-1-yl)furan-2-carboxylic acid (148). To a solution of 147 (124 
mg, 0.601 mmol) in THF (2 mL) and H2O (0.5 mL)was added LiOH (50.5 mg, 1.20 mmol). The 
reaction mixture was stirred at r.t. for 4 h, quenched with 1 N HCl (5 mL), extracted with ethyl 
acetate, dried (Na2SO4), filtered and concentrated under reduced pressure to give 148 (90.0 mg, 
78%) as a white solid:
 
Mp 213.0–215.2 oC; ATR-IR (neat) 3118, 2967, 2922, 2865, 2222, 1668, 
1506, 1418, 1288, 1212, 1159, 1033, 980, 958, 902, 818, 744 cm
-1
;
 1
H NMR (CDCl3, 400 MHz) 
δ 7.87 (br, 1 H), 7.25 (d, 1 H, J = 4.0 Hz), 6.54 (d, 1 H, J = 3.2 Hz), 1.31 (s, 9 H); 13C NMR 
(CDCl3, 125 MHz) δ 162.8, 142.7, 142.1, 120.9, 115.4, 105.2, 69.0, 30.4, 28.2; HRMS (ESI) m/z 
calcd for C11H13O3 ([M+H]
+
) 193.0865, found 193.0847. 
 
 
tert-Butyl (5-(3,3-dimethylbut-1-yn-1-yl)furan-2-yl)carbamate (149). To a stirred 
solution of 148 (176 mg, 0.918 mmol) in t-BuOH (5 mL) was added DPPA (0.198 mL, 0.918 
mmol) and Et3N (0.258 mL, 1.83 mmol). The reaction mixture was refluxed behind the 
protective shield and under constant flow of argon for 12 h. The reaction was quenched by 
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NaOH solution (1.0 M), extracted with ethyl acetate, washed with brine, dried (Na2SO4), filtered 
and concentrated under reduced pressure to give a residue that was purified by chromatography 
on SiO2 (hexanes : EA = 15 : 1) to give 149 (118 mg, 49%) as a pale yellow solid: 
1
H NMR 
(CDCl3, 400 MHz) δ 6.65 (br, 1 H), 6.41 (d, 1 H, J = 3.2 Hz), 5.99 (br, 1 H), 1.50 (s, 9 H), 1.30 
(s, 9 H). 
 
 
(E)-4-((tert-Butoxycarbonyl)(5-(3,3-dimethylbut-1-yn-1-yl)furan-2-yl)amino)-3-
methylbut-2-en-1-yl acetate (113). To a solution of 149 (119 mg, 0.451 mmol) in dry DMF (2.0 
mL) at 0 
o
C was added NaH (27.1 mg, 0.677 mmol, 60 % in mineral oil) in 4 portions. The 
reaction mixture was stirred at 0 
o
C for 1 h. Then, (E)-4-bromo-3-methylbut-2-en-1-yl 
acetate
51
 (98.1 mg, 0.474 mmol) was added dropwise over 5 min. The resulting solution was 
stirred at r.t. for 2 h, diluted with Et2O (10 mL), quenched with saturated aqueous NH4Cl (10 
mL), extracted with Et2O (3 x 10 mL), washed with water and brine, dried (Na2SO4), filtered and 
concentrated under reduced pressure. The crude product was purified by chromatography on 
SiO2 (hexanes : EA = 15 : 1) to give 113 (95.0 mg, 54%) as a yellow liquid: ATR-IR (neat) 
2969, 2928, 2865, 1737, 1715, 1607, 1541, 1448, 1472, 1392, 1364, 1271, 1228, 1158, 1062, 
1020, 980, 857, 779 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) δ 6.38 (d, 1 H, J =3.5 Hz), 5.95 (br, 1 H), 
5.42 (qt, 1 H, J = 1.0, 6.5 Hz), 4.59 (d, 2 H, J = 7.0 Hz), 4.14 (s, 2 H), 2.03 (s, 3 H), 1.70 (s, 3 H), 
1.44 (s, 9 H), 1.30 (s, 9 H); 
13
C NMR(CDCl3, 125 MHz) ) δ 170.9, 153.4, 147.4, 137.0, 132.7, 
62 
   
 
 
120.2, 115.2, 102.0, 101.9, 81.6, 69.5, 60.8, 54.5, 30.7, 28.1, 28.1, 20.9, 14.4; HRMS (ESI) m/z 
calcd for C22H31NO5Na ([M+Na]
+
) 412.2100, found 412.2094. 
 
  
5-(3,3-Dimethylbut-1-yn-1-yl)-3-methyl-1H-indole (114). To a solution of 113 (51 mg, 
0.13 mmol) and P(OiPr)3 (5.5 mg, 0.026 mmol) in NMP (0.65 mL) was added Pd(PPh3)4 (7.6 
mg, 0.0065 mmol). The reaction mixture was stirred under microwave irradiation at 180 
o
C for 
20 min, quenched with ether and water, extracted with ether, washed with brine, dried (Na2SO4), 
filtered and concentrated under reduced pressure. The residue was purified by chromatography 
on SiO2 (hexanes : EA = 16 : 1) to give 114 (15 mg, 52%) as a pale yellow liquid: ATR-IR (neat) 
3415,  2922, 2166, 796 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) δ 7.88 (br, 1 H), 7.65 (s, 1 H), 7.22 
(br, 2 H), 6.95 (s, 1 H), 2.30 (s, 3 H), 1.34 (s, 9 H); 
13
C NMR (CDCl3,125 MHz) δ 135.5, 128.2, 
125.6, 122.5, 122.1, 114.5, 111.9, 110.7, 95.6, 80.2, 31.3, 27.9, 9.6; HRMS (EI) m/z calcd for 
C15H17N 211.1360, found 211.1350. 
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5-(3,3-Dimethylbut-1-yn-1-yl)-4-methylfuran-2-carboxylic acid (150). To a solution 
of methyl  5-(3,3-dimethylbut-1-yn-1-yl)-4-methylfuran-2-carboxylate
61 
(157 mg, 0.713 
mmol) in THF (2 mL) and H2O (0.5 mL) was added LiOH (59.8 mg, 1.43 mmol). The reaction 
mixture was stirred at r.t. for 4 h, quenched with 1 N HCl (10 mL) and extracted with ethyl 
acetate, dried (Na2SO4), filtered and concentrated under reduced pressure to 150 (139 mg, 95%) 
as a white solid: Mp 200.0–202.2 oC; ATR-IR (neat) 3360, 3120, 3025, 2965, 2924, 2231, 1678, 
1620, 1514, 1422, 1379, 1361, 1323, 1202, 1131, 896, 740 cm
-1
;
  1
H NMR (CDCl3, 400 MHz) δ 
8.65 (br, 1 H), 7.15 (s, 1 H), 2.09 (s, 3 H), 1.32 (s, 9 H); 
13
C NMR (CDCl3, 125 MHz) δ 163.0, 
141.8, 139.8, 125.9, 122.4, 107.5, 68.3, 30.6, 28.3, 10.3. HRMS (ESI) m/z calcd for C12H15O3 
([M+H]
+
) 207.1021, found 207.0985. 
 
 
tert-Butyl (5-(3,3-dimethylbut-1-yn-1-yl)-4-methylfuran-2-yl)carbamate (151). To a 
stirred solution of 150 (140 mg, 0.679 mmol) in t-BuOH (5 mL) was added DPPA (0.146 mL, 
0.678 mmol) and Et3N (0.191 mL, 1.36 mmol). The reaction mixture was refluxed behind the 
protective shield and under constant flow of argon for 12 h. The reaction was quenched by 
NaOH solution (1.0 M), extracted with ethyl acetate, washed with brine, dried (Na2SO4), filtered 
and concentrated under reduced pressure to give a residue that was purified by chromatography 
on SiO2 (hexanes : EA = 15 : 1) to give 151 (76.0 mg, 40%) as a pale yellow solid: 
1
H NMR 
(CDCl3, 500 MHz) δ 6.61 (br, 1 H), 5.92 (br, 1 H), 2.02 (s, 3 H), 1.49 (s, 9 H), 1.31 (s, 9 H). 
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(E)-4-((tert-Butoxycarbonyl)(5-(3,3-dimethylbut-1-yn-1-yl)-4-methylfuran-2-
yl)amino)-3-methylbut-2-en-1-yl acetate (115).  To a solution of 151 (76.0 mg, 0.274 mmol) in 
dry DMF (0.5 mL) at 0 
o
C was added NaH (16.4 mg, 0.411 mmol, 60 % in mineral oil) in 4 
portions. The reaction mixture was stirred at 0 
o
C for 1 h. Then, (E)-4-bromo-3-methylbut-2-
en-1-yl acetate
51
 (59.6 mg, 0.288 mmol) was added dropwise over 5 min. The resulting solution 
was stirred at r.t. for 2 h, diluted with Et2O (10 mL), quenched with saturated aqueous NH4Cl (10 
mL), extracted with Et2O (3 x 10 mL), washed with water and brine, dried (Na2SO4), filtered and 
concentrated under reduced pressure. The crude product was purified by chromatography on 
SiO2 (hexanes : EA = 15 : 1) to give 115 (78.0 mg, 71%) as a yellow liquid: ATR-IR (neat) 
2971, 2932, 2158, 1737, 1713, 1618, 1581, 1554, 1500, 1456, 1443, 1392, 1364, 1230, 1159, 
1060, 1023, 951, 857, 831, 777 cm
-1
; 
1
H NMR (CDCl3, 400 MHz) δ 5.88 (br, 1 H), 5.41 (qt, 1 H, 
J = 1.2, 6.8 Hz), 4.59 (d, 2 H, J = 6.8 Hz), 4.13 (s, 2 H), 2.03 (s, 3 H), 2.01 (s, 3 H), 1.69 (s, 3 H), 
1.45 (s, 9 H), 1.31 (s, 9 H); HRMS (ESI) m/z calcd for C23H33NO5Na ([M+Na]
+
) 426.2256, 
found 426.2253. 
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5-(3,3-Dimethylbut-1-yn-1-yl)-3,6-dimethyl-1H-indole (116). To a solution of 115 (54 
mg, 0.13 mmol) and P(OiPr)3 (5.6 mg, 0.027 mmol) in NMP (0.67 mL) was added Pd(PPh3)4 
(7.8 mg, 0.0067 mmol). The reaction mixture was stirred under microwave irradiation at 180 
o
C 
for 20 min, quenched with ether and water, extracted with ether, washed with brine, dried 
(Na2SO4), filtered and concentrated under reduced pressure. The residue was purified by 
chromatography on SiO2 (hexanes : EA = 16 : 1) to give 116 (8.3 mg, 27%) as a pale yellow 
liquid: ATR-IR (neat) 3396,  2922, 2166, 1277, 1124, 1072, 796 cm
-1
; 
1
H NMR (CDCl3, 500 
MHz) δ 7.72 (br, 1 H), 7.61 (s, 1 H), 7.13 (s, 1 H), 6.87 (s, 1 H), 2.49 (s, 3 H), 2.28 (d, 3 H, J = 
1.0 Hz), 1.36 (s, 9 H); HRMS (EI) m/z calcd for C16H19N 225.2517, found 225.1503. 
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2.0 5‑HYDROXYINDOLES BY INTRAMOLECULAR ALKYNOL−FURAN 
DIELS−ALDER CYCLOADDITION 
2.1 INTRODUCTION 
2.1.1 Significance of 5-hydroxyindoles 
5-Hydroxyindoles are found in a vast array of pharmacologically active agents and natural 
products (Figure 5). Furthermore, the hydroxy group can be readily converted to derivatives that 
allow scaffold extensions, cross-coupling or nucleophilic addition reactions of the indole 
nucleus. 
62,63
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Figure 5. Representative biologically active 5-hydroxyindoles 
 
2.1.2 Methods of 5-hydroxyindole synthesis 
General approaches to construct 5-hydroxyindoles include the Nenitzescu reaction,
8
 the 
coumarin−indole transformation,64 and the Pd-catalyzed coupling of 2-iodoanilines with 
alkynes
65
 (Scheme 18). All of these methods feature a linear sequence start from a functionalized 
6-membered ring, then the pyrrole moiety is added to form the indole rings. 
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Scheme 18. Methods for formation of 5-hydroxyindoles 
2.2 RESULTS AND DISCUSSION 
2.2.1 Introduction 
In our previous reaction sequence,
27
 transmetallation of stannane 66 gives lithiated 25. Addition 
of 25 to enones 152 provided the cycloaddition precursors 153. Subjecting these allylic alcohols 
153 to microwave irradiation led to the intitial IMDAF products which underwent 
aromatizations/dehydration and deprotections to provide indoles 30.  
It was envisioned that replacing the enone with alkynone would give us the opportunity 
to branch out from this reaction pathway, eliminate the bridging oxygen atom in 154 to give 155, 
aromatize the intermediate at an earlier stage to give phenol 156, and finally only eliminate a 
single molecule of water and, concomitantly, the N-protective group
66-68
 to yield 5-
hydroxyindole 157. 
69 
   
 
 
 
Scheme 19. Proposed IMDAF reaction pathways for indole and 5-hydroxyindole formation 
 
2.2.2 Examples of the IMDAF reaction for the synthesis of 5-hydroxyindoles 
The synthesis of 5-hydroxyindole begins with formylation of commercial available alkyne 157 to 
afford the alkynal 158. Treatment of 158 to lithiated 25 gives secondary alcohol 159 in 
unoptimized 20−52% yields. Microwave heating to 180 °C for 30 min effected the desired 
IMDAF process and aromatization to give 5-hydroxyindoles 160 after chromatographic 
purification of the reaction mixture on SiO2. 
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157a, R
 
= CH3    158a, R = CH3, 78% 
157b, R = F    158b, R = F,     46% 
157c, R = CF3    158c, R = CF3, 54% 
 
159a, R
 
= CH3, 52%    160a, R = CH3, 47% 
159b, R = F,     20%    160b, R = F,     44% 
159c, R = CF3, 26%    160c, R = CF3, 64% 
Scheme 20. Synthesis of 5-hydroxyindoles from secondary alkynols 
 
The reaction tolerated both electron-withdrawing groups and electron-donating groups in 
the 4-position of indole. No obvious trend for electron-withdrawing or-donating substituents was 
observed for this transformation. Other substrates with 4-alkyl substitutions gave lower yields 
(15-23%) due to the lack of extended conjugation.
45
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2.2.3 Conclusions 
In summary, we have extended our indole synthesis methodology to give synthetically and 
biologically valuable 5-hydroxy indoles by the use of alkynals as starting materials. The starting 
materials are readily available from different substituted alkynes. This convergent procedure is 
compatible with multiple functionalities in the 4-position of the indole, including electron-
withdrawing groups and electron-donating groups. Yields range from 44 to 64% due to the high 
reaction temperature.  
2.3 EXPERIMENTAL SECTION 
General Information: All reactions were performed under an N2 or argon atmosphere and all 
glassware was dried in an oven at 140 °C for 2 h prior to use. Reactions carried out at -78 °C 
employed a CO2/acetone bath. THF was distilled over sodium/benzophenone ketyl, and CH2Cl2 
was purified using an alumina column filtration system. DMF were dried from 4 Å molecule 
sieves. Pyridine and Et3N were dried from KOH. Reactions were monitored by TLC analysis 
(EM Science pre-coated silica gel 60 F254 plates, 250 mM layer thickness) a PMA solution (5 g 
of phosphomolybdic acid in 100 mL of 95% EtOH), p-anisaldehyde solution (2.5 mL of p-
anisaldehyde, 2 mL of AcOH, and 3.5 mL of conc. H2SO4 in 100 mL of 95% EtOH), Vaughn’s 
reagent (4.8 g of (NH4)6Mo7O24•4 H2O and 0.2 g of Ce(SO4)2 in 100 mL of a 3.5 N H2SO4 
solution) or a KMnO4 solution (1.5 g of KMnO4 and 1.5 g of K2CO3 in 100 mL of a 0.1% NaOH 
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solution).  Purifications by chromatography were performed using SiO2 (SiliaFlash
®
 F60, 
Silicycle) or using an ISCO- Companion flash chromatography system. 
1
H/
13
C NMR spectra 
were recorded on Bruker Avance 300/75 MHz, Bruker Avance 400/100 MHz or  Bruker Avance 
500/125 MHz instrument. Chemical shifts were reported in parts per million with the residual 
solvent peak used as the internal standard. Chemical shifts were tabulated as follows: chemical 
shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quarter, dd = doublet of doublet, dt = 
doublet of triplet, m = multiplet, br = broad, app = apparent), coupling constants, and integration. 
Mass spectra were obtained on a Micromass Autospec double focusing instrument. IR spectra 
were obtained on an Identity IR-ATR spectrometer. Microwave reactions were performed using 
a Biotage Initiator in glass microwave vials (cap sealed) with continuous magnetic stirring and 
an external surface temperature sensor. LCMS analyses were completed on a Waters MicroMass 
ZQ with 2525 Binary Gradient Module, 2420 ELSD, 2996 PDA using MeCN/H2O with 0.1% 
TFA. Melting points (uncorrected) were determined using a Mel-Temp instrument. 
 
 
3-(p-Tolyl)propiolaldehyde (158a). To a cooled (-60 
o
C) solution of 4-
methylphenylacetylene (286 mg, 2.46 mmol) in THF (5 mL) was added n-BuLi (2.46 mL, 1.1 M 
in hexanes) with stirring. To this solution was added DMF (0.383 mL, 4.92 mmol) dropwise over 
2 min. The reaction mixture was stirred at r.t. for 20 min, and poured into a mixture of tert-butyl 
methyl ether (10 mL) and 10% KH2PO4 solution (20 mL) at 0 
o
C. The solution was stirred at 0 
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o
C for 30 min, extracted with ethyl acetate, washed with brine, dried, filtered and concentrated 
under reduced pressure to give a residue that was purified by chromatography on SiO2 (hexanes : 
EA = 15 : 1) to give 158a (276 mg, 78%) as a pale yellow liquid: 
1
H NMR (CDCl3, 300 MHz) δ 
9.40 (s, 1 H), 7.49 (d, 2 H, J = 8.4 Hz), 7.20 (d, 2 H, J =8.0 Hz), 2.39 (s, 3 H). The spectral data 
were consistent with those reported in the literature.
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tert-Butyl furan-2-yl(2-hydroxy-4-(p-tolyl)but-3-yn-1-yl)carbamate (159a). To a 
cooled (-78 
o
C) solution of 66 (787 mg, 1.62 mmol) in dry THF (4.0 mL) was added n-BuLi 
(1.62 mL, 1.1 M in hexanes). After 15 min, 158a (117 mg, 0.809 mmol) in THF (1.0 mL) was 
added into the reaction mixture. The solution was stirred at -78 
o
C for 1 h, quenched with ether 
and NH4Cl solution, extracted with EtOAc, washed with brine, dried(Na2SO4) filtered and 
concentrated. The residue was purified by chromatography on SiO2 (hexanes : EA = 15 : 1) to 
give 159a (144 mg, 52%) as a pale yellow liquid: 
1
H NMR (CDCl3, 400 MHz) δ 7.30 (d, 2 H, J 
= 8.0 Hz), 7.19 (dd, 1 H, J = 0.8, 2.0 Hz), 7.10 (d, 2 H, J = 7.6 Hz), 6.34 (dd, 1 H, J = 2.0, 3.2 
Hz), 6.08 (br, 1 H), 4.81 (dt, 1 H, J = 2.0, 8.0 Hz), 3.97 (dd, 1 H, J = 8.0, 14.4 Hz), 3.85 (dd, 1 
H, J = 4.0, 14.4 Hz), 2.34 (s, 3 H), 1.61 (br, 1 H), 1.45 (s, 9 H); 
13
C NMR (CDCl3, 125 MHz) δ 
155.0, 148.2, 138.4, 138.2, 131.6, 128.9, 119.3, 110.9, 101.8, 86.9, 85.8, 81.9, 62.0, 54.7, 28.0, 
21.3; HRMS (ESI) m/z calcd for C20H23NO4Na ([M+Na]
+
) 365.1525, found 364.1494. 
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4-(p-Tolyl)-1H-indol-5-ol (160a). A solution of 159a (35.0 mg, 0.103 mmol) in 1,2-
dichloroethane (1.40 mL) was subjected to microwave irraditation at 180 
o
C for 30 min. The 
reaction mixture was concentrated under reduced pressure to give a residue that was purified by 
chromatography on SiO2 (hexanes : EA = 8 : 1) to give 160a (10.8 mg, 47%) as a pale yellow 
solid: Mp 112.0-113.8 
o
C; ATR-IR (neat) 3523, 3409, 3021, 2917, 2857, 1165, 731 cm
-1
; 
1
H 
NMR (CDCl3, 500 MHz) δ 8.10 (br, 1 H), 7.47 (d, 2 H, J = 8.5 Hz), 7.35 (d, 2 H, J = 8.0 Hz), 
7.27 (dd, 1 H, J = 0.5, 8.5 Hz), 7.17 (app t, 1 H, J = 3.0 Hz), 6.94 (d, 1 H, J = 9.0 Hz), 6.32 (ddd, 
1 H, J = 1.0, 2.0, 3.0 Hz), 5.00 (br, 1 H), 2.45 (s, 3 H); 
13
C NMR (CDCl3, 125 MHz) δ 146.0, 
137.4, 132.5, 130.9, 130.0, 129.8, 127.9, 125.0, 117.8, 111.9, 111.1, 101.7, 21.3; HRMS (ESI) 
m/z calcd for C15H14NO ([M+H]
+
) 224.1075, found 224.1074. 
 
 
3-(4-(Trifluoromethyl)phenyl)propiolaldehyde (158c). To a cooled (-60 
o
C) solution of 
1-ethynyl-4-(trifluoromethyl)benzene (225 mg, 1.32 mmol) in THF (4 mL) was added n-BuLi 
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(1.20 mL, 1.1 M in hexanes) with stirring. To this solution was added DMF (0.205 mL, 2.64 
mmol) dropwise over 2 min. The reaction mixture was stirred at r.t. for 20 min, and poured into a 
mixture of tert-butyl methyl ether (10 mL) and 10% KH2PO4 solution (20 mL) at 0 
o
C. The 
solution was stirred at 0 
o
C for 30 min, extracted with ethyl acetate, washed with brine, dried, 
filtered and concentrated under reduced pressure to give a residue that was purified by 
chromatography on SiO2 (hexanes : EA = 15 : 1) to give 158c (141 mg, 54%) as a pale yellow 
solid: 
1
H NMR (CDCl3, 300 MHz) δ 9.44 (s, 1 H), 7.72 (d, 2 H, J = 8.4 Hz), 7.67 (d, 2 H, J =8.4 
Hz). The spectral data were consistent with those reported in the literature.
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tert-Butylfuran-2-yl(2-hydroxy-4-(4-(trifluoromethyl)phenyl)but-3-yn-1-
yl)carbamate (159c). To a cooled (-78 
o
C) solution of 66 (565 mg, 1.16 mmol) in dry THF (4.0 
mL) was added n-BuLi (1.19 mL, 1.1 M in hexanes). After 15 min, 159b (130 mg, 0.656 mmol) 
in THF (1.0 mL) was added into the reaction mixture. The solution was stirred at -78 
o
C for 1 h, 
quenched with ether and NH4Cl solution, extracted with EtOAc, washed with brine, 
dried(Na2SO4) filtered and concentrated. The residue was purified by chromatography on SiO2 
(hexanes : EA = 15 : 1) to give 159c (66.7 mg, 26%) as a pale yellow liquid: 
1
H NMR (CDCl3, 
500 MHz) δ 7.54 (d, 2 H, J = 8.5 Hz), 7.49 (d, 2 H, J = 8.5 Hz), 7.18 (dd, 1 H, J = 1.0, 2.0 Hz), 
6.34 (dd, 1 H, J = 2.0, 3.0 Hz), 6.07 (br, 1 H), 4.84 (dd, 1 H, J = 4.0, 8.0 Hz), 3.98 (dd, 1 H, J = 
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8.0, 14.5 Hz), 3.89 (dd, 1 H, J = 4.0, 14.5 Hz), 1.44 (s, 9 H); 
13
C NMR (CDCl3, 125 MHz) δ 
155.1, 148.2, 138.4, 132.0, 130.2 (q, J = 32.5 Hz), 126.2, 125.2(q, J = 3.8 Hz), 123.8 (d, J = 
270.5 Hz), 111.1, 101.8, 90.1, 84.4, 82.2, 62.2, 54.6, 28.1; HRMS (ESI) m/z calcd for 
C20H20F3NO4 396.1423, found 396.1404. 
 
 
4-(4-(Trifluoromethyl)phenyl)-1H-indol-5-ol (160c). A solution of 159c (29.4 mg, 
0.0744 mmol) in 1,2-dichloroethane (1.40 mL) was subjected to microwave irraditation at 180 
o
C 
for 30 min. The reaction mixture was concentrated under reduced pressure to give a residue that 
was purified by chromatography on SiO2 (hexanes : EA = 8 : 1) to 160c (13.1 mg, 64%) as a pale 
yellow solid: Mp 140.1-142.4 
o
C; ATR-IR (neat) 3491, 3407, 2922, 2850, 1322, 1165, 1120, 841 
cm
-1
; 
1
H NMR (CDCl3, 500 MHz) δ 8.17 (br, 1 H), 7.79 (d, 2 H, J = 8.0 Hz), 7.73 (d, 2 H, J = 
8.0 Hz), 7.32 (dd, 1 H, J = 0.5, 8.5 Hz), 7.21 (app t, 1 H, J = 3.0 Hz), 6.92 (d, 1 H, J = 9.0 Hz), 
6.31 (ddd, 1 H, J = 1.0, 2.5, 3.0 Hz), 4.76 (br, 1 H); 
13
C NMR (CDCl3, 125 MHz) δ 145.9, 139.9, 
131.0, 130.4, 129.5 (q, J = 32.2 Hz), 127.7, 126.0 (q, J = 3.6 Hz), 125.5, 124.2 (q, J = 270.1 Hz), 
116.7, 112.3, 112.0, 101.4; HRMS (ESI) m/z calcd for C15H11NOF3 ([M+H]
+
) 278.0793, found 
278.0794. 
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3-(4-Fluorophenyl)propiolaldehyde (158b). To a cooled (-60 
o
C) solution of 4-
fluorophenylacetylene (157 mg, 1.31 mmol) in THF (3 mL) was added n-BuLi (1.19 mL, 1.1 M 
in hexanes) with stirring. To this solution was added DMF (0.203 mL, 2.61 mmol) dropwise over 
2 min. The reaction mixture was stirred at r.t. for 20 min, and poured into a mixture of tert-butyl 
methyl ether (10 mL) and 10% KH2PO4 solution (20 mL) at 0 
o
C. The solution was stirred at 0 
o
C for 30 min, extracted with ethyl acetate, washed with brine, dried, filtered and concentrated 
under reduced pressure to give a residue that was purified by chromatography on SiO2 (hexanes : 
EA = 15 : 1) to give 158b (89.0 mg, 46%) as a pale yellow liquid: 
1
H NMR (CDCl3, 400 MHz) δ 
9.41 (s, 1 H), 7.64-7.59 (m, 2 H), 7.11 (tt, 2 H, J =2.4, 8.4 Hz).
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tert-Butyl (4-(4-fluorophenyl)-2-hydroxybut-3-yn-1-yl)(furan-2-yl)carbamate (159b). 
To a cooled (-78 
o
C) solution of 66 (584 mg, 1.20 mmol) in dry THF (3.0 mL) was added n-BuLi 
(1.20 mL, 1.1 M in hexanes). After 15 min, 158b (89.0 mg, 0.601 mmol) in THF (1.0 mL) was 
added into the reaction mixture. The solution was stirred at -78 
o
C for 1 h, quenched with ether 
and NH4Cl solution, extracted with EtOAc, washed with brine, dried (Na2SO4) filtered and 
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concentrated. The residue was purified by chromatography on SiO2 (hexanes : EA = 15 : 1) to 
give 159b (42.0 mg, 20%) as a pale yellow liquid: 
1
H NMR (CDCl3, 400 MHz) δ 7.40-7.36 (m, 2 
H), 7.19 (dd, 1 H, J = 0.8, 2.0 Hz), 6.99 (tt, 2 H, J = 2.0, 8.4 Hz), 6.34 (dd, 1 H, J = 2.0, 4.0 Hz), 
6.07 (br, 1 H), 4.80 (dd, 1 H, J = 4.0, 8.0 Hz), 3.97 (dd, 1 H, J = 8.0, 14.4 Hz), 3.86 (dd, 1 H, J = 
4.0, 14.4 Hz), 3.22 (br, 1 H), 1.45 (s, 9 H); 
13
C NMR (CDCl3, 125 MHz) δ 162.6 (d, J = 248.8 
Hz); 155.4, 148.2, 138.4, 133.7 (d, J = 8.8 Hz), 118.4, 115.5 (d, J = 21.2 Hz), 111.0, 101.8, 87.1, 
84.8, 82.2, 62.3, 54.8, 28.1; HRMS (ESI) m/z calcd for C19H20FNO4 368.1274, found 368.1258. 
 
 
4-(4-Fluorophenyl)-1H-indol-5-ol (160b). A solution of 159b (19 mg, 0.056 mmol) in 
1,2-dichloroethane (1.4 mL) was subjected to microwave irraditation at 180 
o
C for 30 min. The 
reaction mixture was concentrated under reduced pressure to give a residue that was purified by 
chromatography on SiO2 (hexanes : EA = 8 : 1) to 160b (5.6 mg, 44%) as a pale yellow solid: 
Mp 145.6-148.2 
o
C; ATR-IR (neat) 3491, 3409, 2919, 1491, 1353, 1223, 1158, 839 cm
-1
; 
1
H 
NMR (CDCl3, 500 MHz) δ 8.13 (br, 1 H), 7.57-7.53 (m, 2 H), 7.29 (dd, 1 H, J = 1.0, 9.0 Hz), 
7.23 (tt, 2 H, J = 2.0, 9.0 Hz), 7.18 (app t, 1 H, J = 3.0 Hz), 6.93 (d, 1 H, J = 8.5 Hz), 6.28 (ddd, 
1 H, J = 1.0, 2.0, 3.0 Hz), 4.80 (br, 1 H); 
13
C NMR (CDCl3, 125 MHz) δ 162.3 (d, J =245.0 Hz), 
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146.0, 131.8 (d, J = 7.5 Hz), 131.5 (d, J = 2.5 Hz), 130.9, 128.0, 125.2, 116.9, 116.2 (d, J = 24.2 
Hz), 112.1, 111.4, 101.5; HRMS (ESI) m/z calcd for C14H10NOF 228.0825, found 228.0827. 
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3.0 ALKYNE ISOMERIZATION BY NON-NUCLEOPHILIC BASE 
3.1 INTRODUCTION 
In a planned total synthesis of 9-desmethylpleurotin, a promising strategy was to synthesize 
lactone 164 from intermediate 163. The formation of 164 requires an alkyne isomerization 
reaction
72
 (Scheme 21). However, the traditional alkyne isomerization method uses an excess of 
nucleophilic base, which is not compatible with many functional groups, including the lactone 
group in 163. Thus, new reaction conditions using non-nucleophilic base were required for this 
reaction.  
 
 
Scheme 21. Alkyne isomerization in the synthesis of a key intermediate 166 of 9-desmethylpleurotin 
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3.2 RESULTS AND DISCUSSION 
3.2.1 Introduction 
In 1975, Charles Allen Brown and Ayako Yamashita reported the first alkyne zipper reaction 
using potassium 1,3-diaminopropanide generated in situ by adding potassium hydride to the 
solvent 1,3-diaminopropane.
72
 Since its discovery, the alkyne zipper reaction has been widely 
used in organic synthesis. However, the nucleophilic nature of 1,3-diaminopropane limited the 
scope of the reaction. We propose that certain metal catalysts (vide infra) could activate the 
internal alkyne and isomerize it to the terminal alkyne under non-nucleophilic condition as 
shown in Scheme 22. 
 
 
Scheme 22. Proposed mechanism of metal-catalyzed alkyne isomerization 
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3.2.2 Screening of reaction conditions 
3.2.2.1 Screening of bases 
Initial attempts to isomerize the internal alkyne 167 to the terminal alkyne 168 using bases like 
LiHMDS, NaHMDS, KHMDS, tBuOK, DIPEA did not give any detectable product 168 by GC 
analysis. However, the much stronger base LiTMP provided a trace of the desired alkyne 168 
(Table 10). 
 
Table 10. Base variation for the alkyne isomerization reaction
a 
 
Entry Catalyst     Base (2.2 equiv) Conversion
b
  
1 Au(PPh3)Cl (5 mol%) + AgSbF6 (5 mol%) LiHMDS  0 
2 Au(PPh3)Cl (5 mol%) + AgSbF6 (5 mol%) NaHMDS  0 
3 Au(PPh3)Cl (5 mol%) + AgSbF6 (5 mol%) KHMDS  0 
4 Au(PPh3)Cl (5 mol%) + AgSbF6 (5 mol%) t-BuOK  0 
5 Au(PPh3)Cl (5 mol%) + AgSbF6 (5 mol%) LiTMP  trace 
6 Au(PPh3)Cl (5 mol%) + AgSbF6 (5 mol%) DIPEA  0 
7 Au(PPh3)Cl (5 mol%) + AgSbF6 (5 mol%)    0 
8 Au(PPh3)Cl (5 mol%) + AgSbF6 (5 mol%)    0 
9 (Au(PPh3)3)3OBF4 (2 mol%)   LiHMDS  0 
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10 (Au(PPh3)3)3OBF4 (2 mol%)   NaHMDS  0 
11 (Au(PPh3)3)3OBF4 (2 mol%)   KHMDS  0 
12 (Au(PPh3)3)3OBF4 (2 mol%)   t-BuOK  0 
13 (Au(PPh3)3)3OBF4 (2 mol%)   LiTMP  0 
14 (Au(PPh3)3)3OBF4 (2 mol%)   DIPEA  0 
15 (Au(PPh3)3)3OBF4 (2 mol%)      0 
16 (Au(PPh3)3)3OBF4 (2 mol%)      0 
17  (5 mol%)   LiHMDS  0 
18  (5 mol%)   NaHMDS  0 
19  (5 mol%)   KHMDS  0 
20  (5 mol%)   t-BuOK  0 
21  (5 mol%)   LiTMP  0 
22  (5 mol%)   DIPEA  0 
23  (5 mol%)      0 
24  (5 mol%)      0 
a
All reactions were carried out at a concentration of 0.15 M. 
b
GC Conversion. 
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3.2.2.2 Screening of temperature 
With these preliminary results, we decided to investigate which reaction temperatures were 
necessary to promote the isomerization reaction. A 2.7% conversion was obtained after heating 
the reaction mixture at 90 
o
C for 60 h (Entry 3, Table 11). Additional efforts to increase the 
conversion by higher reaction temperature under microwave irradiation only gave trace amounts 
of the desired terminal alkyne 168. 
 
Table 11. Temperature variation for the alkyne isomerization reaction
a 
 
Entry  Solvent  Temperature  Time  Conversion
b
  
1  CH2Cl2  r.t.   12 h  trace 
2  CF3C6H5  60 
o
C   12 h  trace 
3  CF3C6H5  90 
o
C   60 h  2.7% 
4
c
  CF3C6H5  120 
o
C   1 h  trace 
5
c
  CF3C6H5  150 
o
C   1 h  trace 
6
c
  CF3C6H5  180 
o
C   1 h  trace 
a
All reactions were carried out at a concentration of 0.15 M. 
b
GC Conversion. 
c
Reactions were carried out under 
microwave irradiation. 
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3.2.2.3 Catalyst loading 
These initial investigations used 5 mol% catalyst loadings, and control experiment without 
catalyst gave a similar conversion (Entry 2, Table 12). An increase in the reaction concentration 
from 0.15 M to 1.0 M improved the conversion to 74% in the absence of catalyst (Entry 4, 
Table 12). The isomerization reaction almost stopped when excessive AgSbF6 catalyst was 
added (Entry 5, 6, Table 12). 
 
Table 12. Catalyst loading variation for the alkyne isomerization reaction
 
 
Entry Catalyst      Concentration  Conversion
a
  
1 Au(PPh3)Cl (5 mol%) + AgSbF6 (5 mol%)  0.15 M   2.7 %  
2 Au(PPh3)Cl (0 mol%) + AgSbF6 (0 mol%)  0.15 M   2.9 %   
3 Au(PPh3)Cl (5 mol%) + AgSbF6 (5 mol%)  1 M   50 %  
4 Au(PPh3)Cl (0 mol%) + AgSbF6 (0 mol%)  1 M   74 % 
5 Au(PPh3)Cl (5 mol%) + AgSbF6 (25 mol%)  1 M   1.0 % 
6 Au(PPh3)Cl (0 mol%) + AgSbF6 (20 mol%)  1 M   1.0 % 
7 PtCl2 (5 mol%)     1 M   23 % 
a
GC Conversion. 
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3.2.2.4 Solvent variation 
The evaluation of the solvent effect revealed that solvents with strong coordination properties 
significantly improved the conversion in the alkyne isomerization (Entry 3, 7, 8, Table 13). Full 
conversion was achieved when THF was used as solvent at room temperature for 1 h (Entry 7, 
Table 13). 
 
Table 13. Solvent variation for the alkyne isomerization reaction 
 
Entry Solvent  Temperature  Time   Conversion
a
  
1 CF3C6H5  60 
o
C   6 h   86%  
2 CF3C6H5  40 
o
C   6 h   36%  
3 CF3C6H5  r.t.   6 h   2%  
4 THF   40 
o
C   6 h   99% 
5 THF   r.t.   6 h   99% 
6 THF   r.t.   3 h   99% 
7 THF   r.t.   1 h   99% 
8 Ether   r.t.   1 h   68% 
a
GC Conversion. 
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3.2.2.5 Concentration variation 
These initial investigations used 2.2 eq LiTMP at 1.0 M, and efforts to decrease the 
concentration (0.25 M, 0.5 M) resulted in slightly lower conversion (Table 14). Full conversion 
was obtained after a longer reaction time at lower concentration (0.5 M, 3 h). 
 
Table 14. Concentration variation for the alkyne isomerization reaction 
 
Entry    Concentration     Conversion
a
  
1    1 M      99%  
2    0.5 M      80% 
3    0.25 M      73% 
a
GC Conversion. 
3.2.3 Efforts to reduce LiTMP loading 
To further expand the functional groups compatibility with this methodology, a lower loading of 
LiTMP was desired. However, 1.1 eq of LiTMP failed to give full conversion at higher 
temperature (Entry 2, Table 15) or extended reaction time (Entry 1, Table 15). 
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Table 15. Alkyne isomerization reaction with 1.1 eq LiTMP 
 
Entry    Conditions     Conversion
a
  
1    0 
o
C -> r.t., 12 h    33%  
2    0 
o
C -> reflulx, 3 h    62% 
a
GC Conversion. 
 
3.2.4 Examples of alkyne isomerizations using LiTMP 
With optimal reaction conditions determined (2.2 eq LiTMP as base, room temperature for 1 h, 
and 1.0 M substrate concentration in THF), the scope and generality of the reaction was 
evaluated. In general, due to the strongly basic nature of LiTMP, the scope of this methodology 
is limited. THP ether and TBDPS silyl ether give the desired terminal alkyne in 45% and 75% 
yield (Entry 1, 2, Table 16). Benzoyl groups, lactone groups, and cinnamyl ether groups 
suffered from decomposition.  
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Table 16. Scope of the alkyne isomerization reaction with LiTMP 
 
Entry  Precursor   Product  Yield
a 
 
a
Isolated yields. 
 
3.2.5 Conclusions 
After the screening combinations of eight non-nucleophilic bases, four solvents, four catalysts, 
and a series of substrate concentrations, we found that 2.2 equiv of LiTMP in THF (1.0 M 
substrate concentration) at r.t. for 1 h could fully convert an internal to the terminal alkyne. 
However, the strongly basic LiTMP limited the scope of the reaction. In the future, efforts to 
explore milder reaction conditions would be necessary. Potentially, this methodology would 
enable a better route for the total synthesis of 9-desmethylpleurotin. 
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3.3 EXPERIMENTAL SECTION 
General Information: All reactions were performed under an N2 or argon atmosphere and all 
glassware was dried in an oven at 140 °C for 2 h prior to use. Reactions carried out at -78 °C 
employed a CO2/acetone bath. THF was distilled over sodium/benzophenone ketyl, and CH2Cl2 
was purified using an alumina column filtration system. DMF were dried from 4 Å molecule 
sieves. Pyridine and Et3N were dried from KOH. Reactions were monitored by TLC analysis 
(EM Science pre-coated silica gel 60 F254 plates, 250 mM layer thickness) a PMA solution (5 g 
of phosphomolybdic acid in 100 mL of 95% EtOH), p-anisaldehyde solution (2.5 mL of p-
anisaldehyde, 2 mL of AcOH, and 3.5 mL of conc. H2SO4 in 100 mL of 95% EtOH), Vaughn’s 
reagent (4.8 g of (NH4)6Mo7O24•4 H2O and 0.2 g of Ce(SO4)2 in 100 mL of a 3.5 N H2SO4 
solution) or a KMnO4 solution (1.5 g of KMnO4 and 1.5 g of K2CO3 in 100 mL of a 0.1% NaOH 
solution).  Purifications by chromatography were performed using SiO2 (SiliaFlash
®
 F60, 
Silicycle) or using an ISCO- Companion flash chromatography system. 
1
H/
13
C NMR spectra 
were recorded on Bruker Avance 300/75 MHz, Bruker Avance 400/100 MHz or  Bruker Avance 
500/125 MHz instrument. Chemical shifts were reported in parts per million with the residual 
solvent peak used as the internal standard. Chemical shifts were tabulated as follows: chemical 
shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quarter, dd = doublet of doublet, dt = 
doublet of triplet, m = multiplet, br = broad, app = apparent), coupling constants, and integration. 
Mass spectra were obtained on a Micromass Autospec double focusing instrument. IR spectra 
were obtained on an Identity IR-ATR spectrometer. Microwave reactions were performed using 
a Biotage Initiator in glass microwave vials (cap sealed) with continuous magnetic stirring and 
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an external surface temperature sensor. LCMS analyses were completed on a Waters MicroMass 
ZQ with 2525 Binary Gradient Module, 2420 ELSD, 2996 PDA using MeCN/H2O with 0.1% 
TFA. Melting points (uncorrected) were determined using a Mel-Temp instrument. 
 
 
tert-Butyl(pent-4-yn-1-yloxy)diphenylsilane (177). To a cold (0 
o
C) solution of 4-
pentyl-1-ol (2.06 g, 24.5 mmol) and imidazole (5.53 g, 36.7 mmol) in CH2Cl2 was added 
TBDPSCl (7.00 mL, 26.9 mmol) dropwise at 0 
o
C. The solution was stirred at r.t. for 12 h, 
quenched with water, extracted with CH2Cl2 (50 mL), washed with brine, dried (Na2SO4) and 
concentrated under reduced pressure to give a residue that was purified by chromatography on 
SiO2 (hexanes : EA = 50 : 1) to give 177 (7.13 g, 90%) as a colorless liquid: ATR-IR (neat) 3301, 
3070, 2950, 2930, 2855, 2155, 1471, 1426, 1105, 701 cm
-1
;
 1
H NMR (CDCl3, 400 MHz) δ 7.72 
(d, 4 H, J = 8.0 Hz), 7.48-7.40 (m, 6 H), 3.80 (t, 2 H, J = 7.0 Hz), 2.39 (t, 2 H, J = 8.5 Hz), 1.95 
(d, 1 H, J = 1.0 Hz), 1.82 (tt, 2 H, J = 8.0, 8.0 Hz), 1.11 (s, 9 H); 
13
C NMR (CDCl3, 100 MHz) δ 
135.6, 133.8, 129.6, 127.6, 84.2, 68.3, 62.2, 31.4, 26.8, 19.2, 15.0; HRMS (ESI) m/z calcd for 
C21H27OSi ([M+H]
+
) 323.1831, found 323.1856. 
 
 
tert-Butyl(hex-4-yn-1-yloxy)diphenylsilane (167). To a solution of 167 (6.34 g, 19.7 
mmol) in THF (200 mL) was added n-BuLi (8.65 mL, 2.5 M, 21.6 mmol) dropwise at -78 
o
C. 
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The solution was stirred at -78 
o
C for 2 h. Then, MeI (2.45 mL, 39.3 mmol) was added into the 
solution dropwise at -78 
o
C. The reaction mixture was stirred at 0 
o
C for 1 h, quenched with 
saturated NH4Cl, extracted with ethyl acetate, washed with brine, dried (Na2SO4), filtered and 
concentrated under reduced pressure to give a residue that was purified by chromatography on 
SiO2 (hexanes : EA = 50 : 1) to give 167 as a plae yellow liquid (6.36 g, 96%): ATR-IR (neat) 
3070, 3049, 2950, 2930, 2855, 1739, 1588, 1471, 1426, 1103, 1070, 822, 738, 699, 688 cm
-1
;
 1
H 
NMR (CDCl3, 500 MHz) δ 7.69-7.67 (m, 4 H), 7.44-7.36 (m, 6 H), 3.74 (t, 2 H, J = 6.0 Hz), 
2.29-2.26 (m, 2 H), 1.76 (t, 3 H, J = 2.5 Hz), 1.73 (tt, 2 H, J = 7.0, 8.0 Hz), 1.05 (s, 9 H); 
13
C 
NMR (CDCl3, 125 MHz) δ 135.6, 134.0, 129.5, 127.6, 78.8, 75.6, 62.6, 32.0, 26.8, 19.2, 15.0, 
3.4; HRMS (ESI) m/z calcd for C22H29OSi ([M+H]
+
) 337.1988, found 337.1961. 
 
 
tert-Butyl(hex-5-yn-1-yloxy)diphenylsilane (168). Method A. To a cold (0 
o
C) solution 
of 4-hexnyl-1-ol (96.0 mg, 0.978 mmol) and imidazole (221 mg, 1.47 mmol) in CH2Cl2 (3 mL) 
was added TBDPSCl (0.280 mL, 1.08 mmol) dropwise at 0 
o
C. The solution was stirred at r.t. for 
12 h, quenched with water, extracted with CH2Cl2, washed with brine, dried (Na2SO4) and 
concentrated under reduced pressure to give a residue that was purified by chromatography on 
SiO2 (hexanes : EA = 50 : 1) to give 168 (295 mg, 90%) as a colorless liquid: ATR-IR (neat) 
3304, 3070, 3049, 2930, 2857, 2117, 1588, 1471, 1428, 1389, 1361, 1105, 1090, 822, 740, 699, 
686 cm
-1
;
 1
H NMR (CDCl3, 500 MHz) δ 7.78 (d, 4 H, J = 7.0 Hz), 7.52-7.46 (m, 6 H), 3.79 (t, 2 
H, J = 6.0 Hz), 2.28 (dt, 2 H, J = 2.5, 7.0 Hz), 2.01 (t, 1 H, J = 2.5 Hz), 1.80-1.72 (m, 4 H), 1.06 
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(s, 9 H); 
13
C NMR (CDCl3, 100 MHz) δ 135.5, 133.9, 129.5, 127.6, 84.4, 68.3, 64.3, 31.5, 26.8, 
24.9, 19.2, 18.1; HRMS (ESI) m/z calcd for C22H29OSi ([M+H]
+
) 337.1988, found 337.1972. 
Method B. To a degassed stirred solution of 167 (101 mg, 0.299 mmol) in THF (0.3 mL) was 
added LiTMP (96.8 mg, 0.658 mmol) in one portion at 0 
o
C. The solution was stirred at room 
temperature for 15 min, quenched with CH2Cl2 and water, extracted with CH2Cl2, washed with 
brined, dried (Na2SO4) and concentrated under reduced pressure to give a residue that was 
purified by chromatography on SiO2 (hexanes : EA = 50 : 1) to give 168 (75.2 mg, 75%) as a 
pale yellow liquid: 
1
H NMR (CDCl3, 400 MHz) δ 7.70 (d, 4 H, J = 7.6 Hz), 7.45-7.39 (m, 6 H), 
3.71 (t, 2 H, J = 5.6 Hz), 2.22 (dt, 2 H, J = 2.4, 6.8 Hz), 1.96 (t, 1 H, J = 2.4 Hz), 1.69-1.65 (m, 4 
H), 1.08 (s, 9 H). The spectral data were consistent with those from Method A. 
 
 
 
Hex-4-yn-1-ol (178). To 167 (2.30 g, 6.83 mmol) was added TBAF (20.5 mL, 1 M in 
THF) dropwise at 0 
o
C. The reaction mixture was stirred at r.t. for 3 h, quenched with water, 
extracted with ethyl acetate, washed with brine, dried (Na2SO4), filtered and concentrated under 
reduced pressure to give a residue that was purified by chromatography on SiO2 (hexanes : EA = 
4 : 1) to give 178 as a pale yellow liquid (500 mg, 75%): ATR-IR (neat) 3433, 2947, 2919, 2865, 
1700, 1653, 1625, 1463, 1431, 1411, 1383, 1355, 1305, 1275, 1260, 1202, 1187, 1150, 1120, 
1060, 1020, 829, 759, 751, 721, 699 cm
-1
;
 1
H NMR (CDCl3, 500 MHz) δ 3.58 (t, 2 H, J = 6.0 
94 
   
 
 
Hz), 3.03 (br, 1 H), 2.12 (tt, 2 H, J = 2.5, 7.0 Hz), 1.66 (t, 3 H, J  = 2.5 Hz), 1.60 (app dt, 2 H, J = 
7.0, 13.5 Hz); 
13
C NMR (CDCl3, 125 MHz) δ 78.3, 75.7, 61.2, 31.4, 15.0, 3.1. The spectral data 
were consistent with those reported in the literature.
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2-(Hex-4-yn-1-yloxy)tetrahydro-2H-pyran (169). To a solution of 178 (89.5 mg, 0.895 
mmol) in CH2Cl2 (5 mL) was added DHP (0.122 mL, 1.34 mmol) and PPTS (22.5 mg, 0.0895 
mmol) at room temperature. The reaction mixture was stirred at room temperature for 4 h, 
quenched with 1 N HCl (10 mL) and extracted with ethyl acetate, dried (Na2SO4) and 
concentrated under reduced pressure. The residue was purified by chromatography on SiO2 
(hexanes : EA = 15 : 1) to give the 169 (163 mg, 96%) as a colorless liquid: ATR-IR (neat) 2932, 
2929, 2865, 2857, 2850, 1711, 1692, 1640, 1463, 1450, 1439, 1426, 1273, 1135, 1118, 1033, 988, 
902 cm
-1
;
 1
H NMR (CDCl3, 400 MHz) δ 4.50 (t, 1 H, J = 3.6 Hz), 3.79 (tt, 1 H, J = 2.8, 10.8 Hz), 
3.71 (td, 1 H, J = 6.4, 9.6 Hz), 3.37 (tt, 2 H, J = 6.0, 13.6 Hz), 2.14 (dt, 2 H, J = 2.4, 6.8 Hz), 
1.76-1.58 (m, 7 H), 1.51-1.41 (m, 4 H); 
13
C NMR (CDCl3, 100 MHz) δ 98.5, 78.3, 75.4, 65.8, 
61.8, 30.5, 29.0, 25.3, 19.3, 15.4, 3.2. 
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2-(Hex-5-yn-1-yloxy)tetrahydro-2H-pyran (170). To a degassed stirred solution of 169 
(61.7 mg, 0.339 mmol) in THF (0.35 mL) was added LiTMP (110 mg, 0.745 mmol) in one 
portion at 0 
o
C. The solution was stirred at r.t. for 1 h, quenched with water, extracted with 
CH2Cl2, dried (Na2SO4), filtered and concentrated under reduced pressure to give a residue that 
was purified by chromatography on SiO2 (hexanes : EA = 15 : 1 ) to give 170 (27.5 mg, 45 %) as 
a pale yellow liquid: ATR-IR (neat) 3301, 2937, 2865, 1452, 1437, 1351, 1135, 1118, 1074, 
1062, 1033, 1020, 988, 971, 904, 867, 736 cm
-1
;
 1
H NMR (CDCl3, 400 MHz) δ 4.57 (t, 1 H, J = 
4.0 Hz), 3.85 (tt, 1 H, J = 3.2, 11.2 Hz), 3.75 (td, 1 H, J = 6.4 10.0 Hz), 3.49 (td, 1 H, J =4.8, 
10.8 Hz), 3.40 (td, 1 H, J = 4.8, 10.8 Hz), 2.22 (dt, 2 H, J = 2.4, 6.8 Hz), 1.94 (t, 1 H, J = 2.8 Hz), 
1.84-1.77 (m, 1 H), 1.75-1.49 (m, 9 H); 
13
C NMR (CDCl3, 100 MHz) δ 98.7, 84.3, 68.3, 66.8, 
66.2, 30.7, 28.8, 25.4, 25.3, 19.6, 18.2. The spectral data were consistent with those reported in 
the literature.
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Hex-4-yn-1-yl benzoate (171). To a stirred solution of 178 (95.0 mg, 0.968 mmol), 
DMAP (11.8 mg, 0.0118 mmol) in CH2Cl2 (2 mL) was added triethylamine (0.270 mL, 1.94 
mmol) and benzoyl chloride (102 mg, 1.06 mmol) at 0 
o
C. The resulting solution was stirred at 
r.t. for 2 h, quenched with water, extracted with ethyl acetate, washed with brined, dried 
(Na2SO4), filtered and concentrated under reduced pressure to give a residue that was purified by 
chromatography on SiO2 (hexanes : EA = 50 : 1) to give 171 as a pale yellow liquid (160 mg, 
96 
   
 
 
82%): ATR-IR (neat) 3057, 2956, 2917, 2850, 1715, 1599, 1512, 1497, 1459, 1450, 1405, 1385, 
1329, 1312, 1269, 1174, 1113, 1068, 1034, 1025, 952, 749, 708, 688, 673 cm
-1
;
 1
H NMR (CDCl3, 
500 MHz) δ 8.00 (d, 2 H, 7.5 Hz), 7.48 (t, 1 H, J = 7.5 Hz), 7.37 (t, 2 H, J = 7.5 Hz), 4.36 (t, 2 H, 
J = 6.0 Hz), 2.27 (tt, 2 H, J = 3.0, 7.5 Hz), 1.89 (app dt, 2 H, 6.5, 13.5 Hz), 1.71 (s, 3 H); 
13
C 
NMR (CDCl3, 125 MHz) δ 166.2, 132.6, 130.1, 129.3, 128.0, 77.5, 76.0, 63.5, 28.0, 15.4, 3.1; 
HRMS (ESI) m/z calcd for C13H13O2 ([M+H]
+
) 201.0916, found 201.0930. 
 
 
 
(E)-(3-(Hex-4-yn-1-yloxy)prop-1-en-1-yl)benzene (173). To a stirred solution of 178 
(34.0 mg, 0.346 mmol) in THF (1 mL) was added NaH (34.6 mg, 0.866 mmol, 60% in mineral 
oil) in one portion. The solution was stirred at 0 
o
C for 30 min. Then, cinamyl bromide (52.6 mg, 
0.346 mmol) was added into solution in one portion. The solution was stirred at r.t. for 2 h, 
quenched with water, extracted with ethyl acetate, washed with brine, dried (Na2SO4), filtered 
and concentrated under reduced pressure to give a residue that was purified by chromatography 
on SiO2 (hexanes : EA = 15 : 1) to give 173 (67.0 mg, 90%) as a pale yellow liquid: ATR-IR 
(neat) 3047, 3025, 2919, 2852, 1446, 1437, 1364, 1264, 1103, 966, 732, 701, 693 cm
-1
;
 1
H NMR 
(CDCl3, 400 MHz) δ 7.38 (d, 2 H, J = 7.2 Hz), 7.30 (t, 2 H, J = 7.6 Hz), 7.23 (d, 1 H, J = 7.2 Hz), 
6.60 (d, 1 H, J = 16.0 Hz), 6.29 (dt, 1 H, J = 6.0, 16.0 Hz), 4.13 (d, 2 H, J = 5.6 Hz), 3.56 (d, 2 H, 
J = 5.6 Hz), 2.27-2.23 (m, 2 H), 1.78 (q, 2 H, J = 6.4 Hz), 1.75 (s, 3 H); 
13
C NMR (CDCl3, 100 
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MHz) δ 136.8, 132.1, 128.5, 127.5, 126.4, 126.3, 78.5, 75.7, 71.4, 68.9, 29.1, 15.5, 3.4; HRMS 
(ESI) m/z calcd for C15H18O ([M]
+
) 214.1358, found 214.1361. 
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APPENDIX A 
SELECTED NMR DATA 
99 
100 
101 
102 
103 
104 
105 
106 
107 
108 
109 
110 
111 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
138 
139 
140 
141 
142 
143 
144 
145 
146 
147 
148 
149 
150 
151 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
164 
165 
166 
167 
168 
169 
170 
171 
172 
173 
174 
175 
176 
177 
178 
179 
180 
181 
182 
183 
184 
185 
186 
187 
188 
189 
190 
191 
192 
193 
194 
195 
196 
197 
198 
199 
200 
201 
202 
203 
204 
205 
206 
207 
208 
209 
210 
211 
212 
213 
   
 
 
BIBLIOGRAPHY 
(1) de Sa Alves, F. R.; Barreiro, E. J.; Fraga, C. A. M. Mini Rev. Med. Chem. 2009, 9, 782. 
(2) D'Ischia, M.; Napolitano, A.; Pezzella, A.; Katritzky, A. R., Ramsden, C. A., Scriven, E. 
F. V., Taylor, R. J. K., Eds.; Elsevier: Oxford, 2008; Vol. 3, p 353. 
(3) Kochanowska-Karamyan, A. J.; Hamann, M. T. Chem. Rev. 2010, 110, 4489. 
(4) Isaac, M.; Slassi, M.; Xin, T.; Arora, J.; O'Brien, A.; Edwards, L.; MacLean, N.; Wilson, 
J.; Demschyshyn, L.; Labrie, P. Bioorg. Med. Chem. Lett. 2003, 13, 4409. 
(5) Bromidge, S. M.; Dabbs, S.; Davies, D. T.; Duckworth, D. M.; Forbes, I. T.; Ham, P.; 
Jones, G. E.; King, F. D.; Saunders, D. V.; Starr, S. J. Med. Chem. 1998, 41, 1598. 
(6) Top 200 Pharmaceutical Products by Worldwide Sales in 2009 
http://cbc.arizona.edu/njardarson/group/sites/default/files/Top200PharmaceuticalProductsByWor
ldwideSalesin2009.pdf (accessed Mar 10, 2013). 
(7) Zeni, G.; Larock, R. C. Chem. Rev. 2006, 4644. 
(8) Humphrey, G. R.; Kuethe, J. T. Chem. Rev. 2006, 2875. 
(9) Krüger, K.; Tillack, A.; Beller, M. Adv. Synth. Catal. 2008, 350, 2153. 
(10) Patil, N. T.; Yamamoto, Y. Chem. Rev. 2008, 3395. 
(11) Cacchi, S.; Fabrizi, G. Chem. Rev. 2005, 2873. 
(12) Gribble, G. W. Contemp. Org. Synth. 1994, 1, 145. 
(13) Gribble, G. W. J. Chem. Soc., Perkin Trans. 1 2000, 1045. 
(14) Larock, R. C.; Yum, E. K. J. Am. Chem. Soc. 1991, 113, 6689. 
(15) Fürstner, A.; Bogdanović, B. Angew. Chem., Int. Ed. Engl. 1996, 35, 2442. 
(16) Stephens, R. D.; Castro, C. E. J. Org. Chem. 1963, 28, 3313. 
(17) Nicolaou, K. C.; Snyder, S. A.; Montagnon, T.; Vassilikogiannakis, G. Angew. Chem., 
Int. Ed. 2002, 41, 1668. 
(18) Winkler, J. D. Chem. Rev. 1996, 96, 167. 
(19) Diels, O.; Alder, K. Ber. Dtsch. Chem. Ges. 1929, 554. 
(20) Oliver Kappe, C.; Shaun Murphree, S.; Padwa, A. Tetrahedron 1997, 53, 14179. 
(21) Padwa, A.; Brodney, M. A.; Dimitroff, M. J. Org. Chem. 1998, 63, 5304. 
(22) Ginn, J. D.; Padwa, A. Org. Lett. 2002, 4, 1515. 
(23) Bur, S. K.; Lynch, S. M.; Padwa, A. Org. Lett. 2002, 4, 473. 
(24) Boonsompat, J.; Padwa, A. J. Org. Chem. 2011, 76, 2753. 
(25) Padwa, A.; Brodney, M. A.; Liu, B.; Satake, K.; Wu, T. J. Org. Chem. 1999, 64, 3595. 
(26) Padwa, A.; Bur, S. K.; Zhang, H. J. Org. Chem. 2005, 70, 6833. 
214 
   
 
 
(27) Petronijevic, F.; Timmons, C.; Cuzzupe, A.; Wipf, P. Chem. Commun. 2009, 104. 
(28) Petronijevic, F. R.; Wipf, P. J. Am. Chem. Soc. 2011, 133, 7704. 
(29) Trost, B. M. Acc. Chem. Res. 1980, 13, 385. 
(30) Tsuji, J.; Iwamoto, N.; Morikawa, M. Bull. Chem. Soc. Jpn. 1965, 2213. 
(31) Trost, B. M.; Fullerton, T. J. J. Am. Chem. Soc. 1973, 95, 292. 
(32) Ito, Y.; Hirao, T.; Saegusa, T. J. Org. Chem. 1978, 43, 1011. 
(33) Chen, M. S.; Prabagaran, N.; Labenz, N. A.; White, M. C. J. Am. Chem. Soc. 2005, 127, 
6970. 
(34) Saitoh, A.; Achiwa, K.; Tanaka, K.; Morimoto, T. J. Org. Chem. 2000, 65, 4227. 
(35) Nomura, N.; Tsurugi, K.; Okada, M. Angew. Chem., Int. Ed. 2001, 40, 1932. 
(36) Trost, B. M.; Crawley, M. L. Chem. Rev. 2003, 103, 2921. 
(37) Trost, B. M.; Radinov, R.; Grenzer, E. M. J. Am. Chem. Soc. 1997, 119, 7879. 
(38) Larock, R. C.; Hightower, T. R.; Kraus, G. A.; Hahn, P.; Zheng, D. Tetrahedron Lett. 
1995, 36, 2423. 
(39) Porth, S.; Bats, J. W.; Trauner, D.; Giester, G.; Mulzer, J. Angew. Chem., Int. Ed. 1999, 
38, 2015. 
(40) Toyota, M.; Ihara, M. Synlett 2002, 2002, 1211. 
(41) Chen, M. S.; White, M. C. J. Am. Chem. Soc. 2004, 126, 1346. 
(42) Fraunhoffer, K. J.; White, M. C. J. Am. Chem. Soc. 2007, 129, 7274. 
(43) Young, A. J.; White, M. C. J. Am. Chem. Soc. 2008, 130, 14090. 
(44) Stang, E. M.; White, M. C. J. Am. Chem. Soc. 2011, 133, 14892. 
(45) LaPorte, M.; Hong, K. B.; Xu, J.; Wipf, P. J. Org. Chem. 2013, 78, 167. 
(46) Braddock, D. C.; Matsuno, A. Tetrahedron Lett. 2002, 43, 3305. 
(47) Kuhnert, N. Angew. Chem., Int. Ed. 2002, 41, 1863. 
(48) de la Hoz, A.; Diaz-Ortiz, A.; Moreno, A. Chem. Soc. Rev. 2005, 34, 164. 
(49) de la Hoz, A.; Díaz-Ortis, A.; Moreno, A.; Langa, F. Eur. J. Org. Chem. 2000, 2000, 
3659. 
(50) Mazur, Y.; Karger, M. H. J. Org. Chem. 1971, 36, 532. 
(51) Van, T. N.; De Kimpe, N. Tetrahedron 2000, 56, 7969. 
(52) Okuro, K.; Gurnham, J.; Alper, H. J. Org. Chem. 2011, 76, 4715. 
(53) Doi, N.; Kimura, K.; Seko, S.; Takahashi, T.  Process for producing allyl halide 
compound. U.S. Patent 20,020,107,422, 2002. 
(54) Henric, A. N.; Ove, K. W.; Henric, H. J. Allosteric Binding Compounds. W.O. Patent 
2,010,094,289, 2010. 
(55) Padwa, A.; Brodney, M. A.; Satake, K.; Straub, C. S. J. Org. Chem. 1999, 64, 4617. 
(56) Jensen, T.; Pedersen, H.; Bang-Andersen, B.; Madsen, R.; Jørgensen, M. Angew. Chem., 
Int. Ed. 2008, 47, 888. 
(57) Boukouvalas, J.; Loach, R. P.; Ouellet, E. Tetrahedron Lett. 2011, 52, 5047. 
(58) Cho, C. S.; Kim, J. H.; Kim, T.-J.; Shim, S. C. Tetrahedron 2001, 57, 3321. 
(59) Bilodeau, F.; Brochu, M.-C.; Guimond, N.; Thesen, K. H.; Forgione, P. J. Org. Chem. 
2010, 75, 1550. 
(60) Braisted, A. C.; Oslob, J. D.; Delano, W. L.; Hyde, J.; McDowell, R. S.; Waal, N.; Yu, 
C.; Arkin, M. R.; Raimundo, B. C. J. Am. Chem. Soc. 2003, 125, 3714. 
215 
   
 
 
(61) Bach, T.; Krüger, L. Eur. J. Org. Chem. 1999, 1999, 2045. 
(62) Riendeau, D.; Aspiotis, R.; Ethier, D.; Gareau, Y.; Grimm, E. L.; Guay, J.; Guiral, S.; 
Juteau, H.; Mancini, J. A.; Méthot, N.; Rubin, J.; Friesen, R. W. Bioorg. Med. Chem. Lett. 2005, 
15, 3352. 
(63) Im, G. Y. J.; Bronner, S. M.; Goetz, A. E.; Paton, R. S.; Cheong, P. H. Y.; Houk, K. N.; 
Garg, N. K. J. Am. Chem. Soc. 2010, 132, 17933. 
(64) Stoffman, E. J. L.; Clive, D. L. J. Org. Biomol. Chem. 2009, 7, 4862. 
(65) Ezquerra, J.; Pedregal, C.; Lamas, C.; Barluenga, J.; Pérez, M.; García-Martín, M. A.; 
González, J. M. J. Org. Chem. 1996, 61, 5804. 
(66) Wasserman, H. H.; Berger, G. D.; Cho, K. R. Tetrahedron Lett. 1982, 23, 465. 
(67) Yamatsugu, K.; Yin, L.; Kamijo, S.; Kimura, Y.; Kanai, M.; Shibasaki, M. Angew. 
Chem., Int. Ed. Engl. 2009, 48, 1070. 
(68) Rawal, V. H.; Cava, M. P. Tetrahedron Lett. 1985, 26, 6141. 
(69) Métay, E.; Hu, Q.; Negishi, E.-i. Org. Lett. 2006, 8, 5773. 
(70) Oida, S.; Tanaka, T.; Tajima, Y.; Konosu, T.; Somada, A.; Miyaoka, T.; Yasuda, H. 
Triazole antifungal agent. U.S. Patent 597,715,2, 1999. 
(71) Wadsworth, D. H.; Geer, S. M.; Detty, M. R. J. Org. Chem. 1987, 52, 3662. 
(72) Brown, C. A.; Yamashita, A. J. Am. Chem. Soc. 1975, 97, 891. 
(73) Seo, S.; Yu, X.; Marks, T. J. J. Am. Chem. Soc. 2008, 131, 263. 
(74) Zhao, L.; Lu, X.; Xu, W. J. Org. Chem. 2005, 70, 4059. 
 
 
216 
